Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
Simone Lista
Based on 46 articles published since 2009
(Why 46 articles?)
||||
Expertise Level
The expertise of Simone Lista ranks in the
  • Top 0.06%
  • ... of 104,242 published authors worldwide on Alzheimer Disease
  • ... from 2009 through 2019
  • ... based on contributions to 46 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Lista, S   ·   Lista, Simone
Work Locations
Details
Most likely:    Sorbonne University      
2018
  • AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013 Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013 Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013 Paris, France. Electronic address: · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013 Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013 Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013 Paris, France. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Department of Neurology, College of Medicine, Hanyang University, Seoul, Republic of Korea; Cell Therapy Center, Hanyang University Hospital, Seoul, Republic of Korea. · Breast and Menopause Clinic, Ghent University Hospital, Corneel Heymanslaan 10, B-9000 Ghent, Belgium. · Department of Physiology and Pharmacology "Vittorio Erspamer", University of Rome "Sapienza", Rome, Italy. · Neuropharmacology Lab, European Brain Research Institute (E.B.R.I.), Rome, Italy. · Neuropharmacology Lab, European Brain Research Institute (E.B.R.I.), Rome, Italy; Department of Biology, University of Rome "Tor Vergata", Rome, Italy. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013 Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013 Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013 Paris, France. Electronic address: · Pubmed 29902481
  • AXA Research Fund & Sorbonne Université Chair, Paris, France. · Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Boulevard de l'hôpital, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy. · Department of Radiology, "Athinoula A. Martinos" Center for Biomedical Imaging, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Department of Physiology and Pharmacology "Vittorio Erspamer", University of Rome "La Sapienza", Rome, Italy. · Institute for Research and Medical Care, IRCCS "San Raffaele Pisana", Rome, Italy. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Department of Neurosurgery, Maxine Dunitz Neurosurgical Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience (TCIN), Trinity College Dublin, Dublin, Ireland. · Unit of Neurosurgery, Azienda Ospedaliera Universitaria Senese, Siena, Italy. · IRCCS "San Giovanni di Dio-Fatebenefratelli", Brescia, Italy. · Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM) Paris, France; Inria, Aramis project-team, Centre de Recherche de Paris, France; Department of Neuroradiology, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France; Department of Neurology, AP-HP, Hôpital de la Pitié-Salpêtrière, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Paris, France. · Sorbonne Université, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM) Paris, France; Inria, Aramis project-team, Centre de Recherche de Paris, France. · IREM, Institute for Regenerative Medicine, University of Zurich, Zürich, Switzerland. · ZNZ Neuroscience Center Zurich, Zürich, Switzerland. · Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Inserm U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle Épinière, ICM, Ecole Normale Supérieure, ENS, Centre MEG-EEG, Paris, France. · Département de Médecine Nucléaire, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · Laboratoire d'Imagerie Biomédicale, Sorbonne Universités, UPMC Univ Paris 06, Inserm U 1146, CNRS UMR 7371, Paris, France. · Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK. · Division of Informatics, Imaging and Data Sciences, University of Manchester, Wolfson Molecular Imaging Centre, Manchester, UK. · Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Functional Neuromodulation, Ltd., Boston, MA, USA. · Centre de NeuroImagerie de Recherche - CENIR, Institut du Cerveau et de la Moelle Épinière - ICM, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Inserm U 1127, CNRS UMR 7225, ICM, Paris, France. · Institut de la Vision, INSERM, Sorbonne Universités, UPMC Univ Paris 06, UMR_S968, CNRS UMR7210, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, CNRS UMR 8256, Institut de Biologie Paris-Seine (IBPS), Place Jussieu, Paris, France. · Department of Biology, University of Rome "Tor Vergata" & Pharmacology of Synaptic Disease Lab, European Brain Research Institute (E.B.R.I.), Rome, Italy. · Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. · Department of Medicine, Surgery and Neurosciences, Unit of Neurology and Clinical Neurophysiology, Brain Investigation & Neuromodulation Lab. (Si-BIN Lab.), University of Siena, Siena, Italy. · Department of Medicine, Surgery and Neurosciences, Section of Human Physiology University of Siena, Siena, Italy. · Berenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. · Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA. · IU Network Science Institute, Indiana University, Bloomington, IN, USA. · NeuroVision Imaging LLC, Sacramento, CA, USA. · ITTM Solutions, Esch-sur-Alzette, Luxembourg. · Casa di Cura "San Raffaele Cassino", Cassino, Italy. · Pubmed 29562524
  • AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Department of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada. · Biostatistics and Special Pharmacokinetics Unit/Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Health Affairs CEO, UCI Health, University of California, Irvine, CA, USA. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Neurological Surgery, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Anatomy & Neurobiology, University of California Irvine School of Medicine, Irvine, CA, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Neurology/Psychiatry/Ophthalmology Unit, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Foundational Neuroscience Center (FNC), AbbVie Neuroscience, Cambridge, MA, USA; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK; Institute of Neurodegenerative Diseases, Catholic University of Leuven, Leuven, Belgium. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA. · College of Sciences, One UTSA Circle, The University of Texas at San Antonio, San Antonio, TX, USA. · Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. · Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. · Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · Pubmed 29458203
  • Genetadi Biotech S.L. Parque Tecnológico de Bizkaia, Derio, Bizkaia, Spain. · AXA Research Fund & UPMC Chair, F-75013, Paris, France. · Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. · Pubmed 29512064
  • Centre des Maladies Cognitives et Comportementales, Sorbonne Université, Hôpital de la Salpêtrière, Paris, France. Electronic address: · Centre des Maladies Cognitives et Comportementales, Sorbonne Université, Hôpital de la Salpêtrière, Paris, France. · IQVIA, Saint-Ouen, France. · Institut du Cerveau et de la Moelle Epinière (ICM), Institute of Memory and Alzheimer's Disease (IM2A), Centre of Excellence of Neurodegenerative Disease (CoEN), Sorbonne Université, Hôpital de la Salpêtrière, Paris, France. · Inria ARAMIS Project Team, Department of Neuroradiology, Sorbonne Université, Hôpital de la Salpêtrière, Paris, France. · Service de Biochimie Métabolique, Sorbonne Université, Hôpital de la Salpêtrière, Paris, France. · Laboratoire d'Imagerie Biomédicale, Nuclear Medicine Department, Sorbonne Université, Hôpital de la Salpêtrière, Paris, France. · Neurospin, Institut d'Imagerie BioMédicale, Le Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Gif-sur-Yvette, France. · Pubmed 29500152
  • AXA Research Fund & Sorbonne Université Chair, Paris, France; Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Department of Radiology, "Athinoula A. Martinos" Center for Biomedical Imaging, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · AXA Research Fund & Sorbonne Université Chair, Paris, France; Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK; UK Dementia Research Institute, London, UK. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Psychosomatic Medicine, University of Rostock & DZNE Rostock, Rostock, Germany. · AXA Research Fund & Sorbonne Université Chair, Paris, France; Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France; IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Casa di Cura "San Raffaele Cassino", Cassino, Italy. · Pubmed 29328927
  • Neurodegenerative Disorder Research Center and Brain Bank, Material Science at Microscale National Laboratory, School of Life Sciences, Key Laboratory of Brain Function and Disease, Chinese Academy of Sciences, University of Science and Technology of China, Hefei; Center for Advanced, Therapeutic Strategies for Brain Disorders, Sarasota; Department of Neurology, University of Florida College of Medicine, Gainesville, Florida. · Roskamp Institute, Sarasota. · Memory Center, Sarasota. · Department of Economics, Arizona State University, Tempe, Arizona. · Paris Institute of Translational Neurosciences IHU-A-ICM, Pitié-Salpêtrière University Hospital; AXA Research Fund & Université Pierre et Marie Curie Chair, Sorbonne Universités, Université Pierre et Marie Curie Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle. · Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen; Center of Old Age Psychiatry, Psychiatric University Hospital, Basel, Switzerland. · Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen. · Department of Psychiatry and Psychotherapy, Alzheimer Memorial Center, Ludwig-Maximilian University, Munich, Germany. · Department of Neurology and Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, Georgia. · Department of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden. · Beijing Anding Hospital, Capital Medical University & Beijing Key Laboratory of Mental Disorders, Beijing; Beijing Institute for Brain Disorders, Beijing, China; Center for Hormone Advanced Science and Education, Sarasota. Electronic address: · Paris Institute of Translational Neurosciences IHU-A-ICM, Pitié-Salpêtrière University Hospital; AXA Research Fund & Université Pierre et Marie Curie Chair, Sorbonne Universités, Université Pierre et Marie Curie Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle; Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer, Hôpital Pitié-Salpêtrière, Paris, France. · Pubmed 28359566
2017
  • AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universities, Pierre and Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France. Electronic address: · AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universities, Pierre and Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France; Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universities, Pierre and Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France. · Imaging Genetics Center, Stevens Institute for Neuroimaging & Informatics, Keck School of Medicine, University of Southern California, Los Angeles, CA 90232, USA. · AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universities, Pierre and Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France. Electronic address: · Pubmed 28684173
  • AXA Research Fund & UPMC Chair, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et dela moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), HôpitalPitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX, USA. · The Torsten Söderberg Professorship in Medicine at the Royal Swedish Academy of Sciences, Stockholm, Sweden. · AXA Research Fund & UPMC Chair, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) & Institut du Cerveau et de la Moelle Épinière (ICM), Paris, France; Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Pubmed 28508359
  • a AXA Research Fund & UPMC Chair , Paris , France. · b Département de Neurologie , Sorbonne Universités, Université Pierre et Marie Curie (UPMC), Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital , Paris , France. · c Institute for Healthy Aging , University of North Texas Health Science Center , Fort Worth , TX , USA. · d ARAMIS Lab, Inria Paris , Paris , France. · e Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, Institut du cerveau et la moelle (ICM), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital , Paris , France. · f European Society for Translational Medicine , Vienna , Austria. · g Medical Research Council Centre for Neuropsychiatric Genetics and Genomics , Cardiff University , Cardiff , UK. · h Département de Neurologie , Sorbonne Université, Université Pierre et Marie Curie, Paris 06 UMR S 1127, Institut National de Santé et en Recherche Médicale (INSERM) U 1127 and CIC-1422, Centre National de Recherche Scientifique U 7225, Institut du Cerveau et de la Moelle Epinière, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière , Paris , France. · i President, Federal Institute for Drugs and Medical Devices (BfArM) , Bonn , Germany. · Pubmed 28286989
  • a Department of Clinical and Experimental Medicine , University of Pisa , Pisa , Italy. · b AXA Research Fund UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie , Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital , Paris , France. · c IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli , Brescia , Italy. · Pubmed 28281838
  • AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; ICM, CNRS UMR 7225, Inserm U 1127, UPMC-P6 UMR S 1127, GH Pitié-Salpêtrière, Paris, France. Electronic address: · AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · ICM, CNRS UMR 7225, Inserm U 1127, UPMC-P6 UMR S 1127, GH Pitié-Salpêtrière, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de médecine nucléaire, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratoire de Biochimie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; ICM, CNRS UMR 7225, Inserm U 1127, UPMC-P6 UMR S 1127, GH Pitié-Salpêtrière, Paris, France. · AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; IHU-A-ICM, Paris Institute of Translational Neurosciences, Hôpital de la Pitié-Salpêtrière, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. · AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; ICM, CNRS UMR 7225, Inserm U 1127, UPMC-P6 UMR S 1127, GH Pitié-Salpêtrière, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. · Pubmed 28188032
  • a AXA Research Fund & UPMC Chair , Paris , France. · b IHU-A-ICM - Paris Institute of Translational Neurosciences , Pitié-Salpêtrière University Hospital , Paris , France. · c Department of Neurology, Sorbonne Universities, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Pitié-Salpêtrière University Hospital , Pierre and Marie Curie University , Paris 06, Paris , France. · Pubmed 27332958
  • AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Hopital Pitié-Salpêtrière, Paris, France. · Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · German Center for Neurodegenerative Diseases (DZNE) - Rostock/Greifswald, Rostock, Germany. · Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. · Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, Institut du cerveau et la moelle (ICM), APHP- Hôpital Pitié-Salpêtrière, Paris, France. · Inria, Aramis project-team, Centre de Recherche de, Paris, France. · AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Hopital Pitié-Salpêtrière, Paris, France. · CATI - Centre d'Acquisition et de Traitement des Images, Paris, France. · AP-HP, Neuroradiology Department, Hôpital de la Pitié-Salpêtrière, Paris, France. · Institute of Memory and Alzheimer's Disease (IM2A), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Pitié-Salpêtrière, University Paris 6, Paris, France. · CENIR, Hôpital de la Salpêtriere, Paris, France. · INSERM U1127, Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France. · Sorbonne Universites, Universite Pierre et Marie Curie-Paris 6, Paris, France. · Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Hopital Pitié-Salpêtrière, Paris, France. · AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Hopital Pitié-Salpêtrière, Paris, France. · Pubmed 28916821
  • Department of Neurology, Institute of Memory and Alzheimer's Disease, Pitié-Salpêtrière University Hospital, Paris, France. · AXA Research Fund and UPMC Chair, Paris, France. · Department of Nuclear Medicine, Charité, Berlin, Germany. · Jung diagnostics GmbH, Hamburg, Germany. · Department of Neurology, Institute of Memory and Alzheimer's Disease, National Reference Center for Rare Dementias, Pitié Salpêtrière University Hospital, Paris, France. · Brain and Spine Institute (ICM) - INSERM 1127, Frontlab, Paris, France. · Pubmed 28869481
  • AXA Research Fund and UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · IRCCS Centro San Giovanni di Dio, Brescia, Italy. · Department of Nuclear Medicine, Charité- Universitätsmedizin Berlin, Berlin, Germany. · Jung diagnostics GmbH, Hamburg, Germany. · Eli Lilly and Company, Indianapolis, IN, USA. · Department of Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28777748
  • AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Department of Radiology, "Athinoula A. Martinos" Center for Biomedical Imaging, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; The Torsten Söderberg Professorship in Medicine at the Royal Swedish Academy of Sciences, Sweden. · Department of Psychosomatic Medicine, University of Rostock & DZNE Rostock, Rostock, Germany. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France; IRCCS "San Giovanni di Dio-Fatebenefratelli", Brescia, Italy. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Casa di Cura "San Raffaele Cassino", Cassino, Italy. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Pubmed 28527630
  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy; Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Psychosomatic Medicine, University of Rostock and DZNE, Rostock, Germany. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France; AXA Research Fund & UPMC Chair, Paris, France; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. · Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy; Casa di Cura "San Raffaele Cassino", Cassino, Frosinone, Italy. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. Electronic address: · Pubmed 28263742
  • Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX, USA. Electronic address: · Department of Neurology, Mayo Clinic, Rochester, MN, USA; Department of Health Science Research, Mayo Clinic, Rochester, MN, USA. · Alzheimer's Disease Cooperative Study, Department of Neurosciences, UCSD School of Medicine, La Jolla, CA, USA. · AXA Research Fund and UPMC Chair, Paris, France; Department de Neurologie, Institut de la Memorie et de la Maladie d'Alzheimer (IM2A) et Institut du Cerveau et du la Moelle epiniere (ICM), Hospital de la Pitie-Salpetriere, Sorbonne Universites, Universite Pierre et Marie Curie, Paris, France. · ADx NeuroSciences NV, Ghent, Belgium. · Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gotenburg, Molndal, Sweden; UCL Institute of Neurology, London, UK. · Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany; Department of Neurodegeneration Diagnostics, Medical University of Bialystok, Bialystok, Poland. · Pfizer, Inc., New York, USA. · Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX, USA. · Johnson & Johnson, London Innovation Center, London, UK. · Neuroscience Clinical Development, Clinical Neuroscience Eisai, Woodcliff Lake, NJ, USA. · Quanterix Corporation, Lexington, MA, USA. · Roche Diagnostics International Ltd., Rotkreuz, Switzerland. · Centro de Neurociencias y Unidad de Investigacion Clinica, Instituto de Investigaciones Cientificas y Servicios de Alta Tecnologia (INDICASAT AIP), Ciudad del Saber, Panama, Panama. · Department of Neurology, Rhode Island Hospital and Alpert Medical School of Brown University, Providence, RI, USA. · Neurodegenerative Diseases, Nordic Bioscience Biomarkers and Research, Herlev, Denmark. · George and Anne Ryan Institute for Neuroscience, University of Rhode Island, RI, USA. · Faculty of Health, Engineering and Sciences, Center of Excellence for Alzheimer's Disease Research and Care, School of Medical Sciences, Edith Cowan University, Joondalup, WA, Australia. · Pubmed 27870940
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal Hospital, 43180, Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal Hospital, 43180, Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Neuropsychiatry, Skaraborg Hospital, Falköping, Sweden. · Institute of Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. · Department of Endocrinology, Skaraborg Hospital, 541 85, Skövde, Sweden. · AXA Research Fund & UPMC Chair, Paris, France. · IHU-A-ICM-Paris Institute of Translational Neurosciences, Pitié-Salpêtrière University Hospital, Paris, France. · Sorbonne Universities, Pierre and Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Pitié-Salpêtrière University Hospital, Paris, France. · Department of Pathology, Haartman Institute, University of Helsinki, Helsinki, Finland. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, WC1N1PJ, UK. · Pubmed 27646979
2016
  • Institute of Memory and Alzheimer's Disease (IM2A) and Brain and Spine Institute (ICM) UMR S 1127 Frontlab, Department of Neurology, AP_HP, Pitié-Salpêtrière University Hospital, Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Paris, France. Electronic address: · Institute of Memory and Alzheimer's Disease (IM2A) and Brain and Spine Institute (ICM) UMR S 1127 Frontlab, Department of Neurology, AP_HP, Pitié-Salpêtrière University Hospital, Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. · University of British Columbia, Canada. · Department of Neurology and Alzheimer Center, VU University Medical Center and Neuroscience Campus, Amsterdam, The Netherlands. · University of Southern California San Diego, CA, USA. · UMR1027, INSERM, Université Toulouse III, Toulouse University Hospital, France. · IHU-A-ICM-Institut des Neurosciences translationnelles de Paris, Paris, France. · INSERM U1146-CNRS UMR 7371-UPMC UM CR2, Site Pitié-Salpêtrière, Paris, France. · Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), Institutes of Neurogenetics and Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; School of Public Health, Faculty of Medicine, Imperial College London, London, UK. · Clinical Neurochemistry Lab, Department of Neuroscience and Physiology, University of Gothenburg, Mölndal Hospital, Sahlgrenska University Hospital, Mölndal, Sweden. · Federal Institute for Drugs and Medical Devices, Bonn, Germany. · AXA Research Fund & UPMC Chair, Paris, France; Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK. · INSERM U 1219, Université de Bordeaux, France. · University Pierre et Marie Curie, Assistance Publique des Hôpitaux de Paris, Alzheimer-Prion Team Institut du Cerveau et de la Moelle (ICM), Paris, France. · Institute of Memory and Alzheimer's Disease (IM2A) and Brain and Spine Institute (ICM) UMR S 1127 Frontlab, Department of Neurology, AP_HP, Pitié-Salpêtrière University Hospital, Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Paris, France. · University Hospitals and University of Geneva, Geneva, Switzerland; IRCCS Fatebenefratelli, Brescia, Italy. · McGill Center for Studies in Aging, Douglas Mental Health Research Institute, Montreal, Canada. · Fondation pour la Recherche sur Alzheimer, Hôpital Pitié-Salpêtrière, Paris, France. · UMR1027, INSERM, Université Toulouse III, Toulouse University Hospital, France; Department of Clinical Neurophysiology/MEG Center, VU University Medical Center, Amsterdam. · Sorbonne Universités, UPMC Univ Paris 06, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, Paris, France; AP-HP, Hôpital Pitié-Salpêtrière, Département de Médecine Nucléaire, Paris, France. · Department of Neurology, Washington University, Hope Center for Neurological Disorders, St. Louis, MO, USA; Department of Neurology, Washington University, Knight Alzheimer's Disease Research Center, St. Louis, MO, USA. · Center for Alzheimer Research, Karolinska Institutet, Department of Geriatric Medicine, Karolinska University Hospital, Stockholm, Sweden; Institute of Clinical Medicine/ Neurology, University of Eastern Finland, Kuopio, Finland. · AXA Research Fund & UPMC Chair, Paris, France. · Alzheimer's Disease and Other Cognitive Disorders Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Barcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain. · Center for Alzheimer's & Neurodegenerative Disease Research, University of North Texas Health Science Center, TX, USA. · Memory & Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, USA. · Department of Molecular Imaging, Austin Health, University of Melbourne, Australia. · Memory and Aging Program, Butler Hospital, Alpert Medical School of Brown University, USA; Department of Neurology, Alpert Medical School of Brown University, USA; Department of Psychiatry, Alpert Medical School of Brown University, USA. · Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. · Harvard Medical School, Memory Disorders Unit, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Boston, USA; Harvard Medical School, Memory Disorders Unit, Center for Alzheimer Research and Treatment, Massachusetts General Hospital, Boston, USA. · The Alzheimer's Association Division of Medical & Scientific Relations, Chicago, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Department of Radiology, Mayo Clinic, Rochester MN, USA. · Pubmed 27012484
  • German Center for Neurodegenerative Diseases (DZNE) - Rostock/Greifswald, Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. Electronic address: · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; INSERM U1127, Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France; Sorbonne Universites, Universite Pierre et Marie Curie-Paris 6, Paris, France; CATI Multicenter Neuroimaging Platform, France; IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli, Italy. · German Center for Neurodegenerative Diseases (DZNE) - Rostock/Greifswald, Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; INSERM U1127, Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France; Sorbonne Universites, Universite Pierre et Marie Curie-Paris 6, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. · IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli, Italy. · Inserm, U1127, F-75013, Paris, France; CNRS, UMR 7225 ICM, 75013, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France; Inria, Aramis Project-team, Centre de Recherche Paris-Rocquencourt, France. · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; IHU-A-ICM - Paris Institute of Translational Neurosciences, Paris, France. · Inserm, U1127, F-75013, Paris, France; CNRS, UMR 7225 ICM, 75013, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France; Neuroradiology Department, Hôpital de la Salpêtriere, Paris, France. · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; INSERM U1127, Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France; Sorbonne Universites, Universite Pierre et Marie Curie-Paris 6, Paris, France. · Pubmed 26876309
  • Université Pierre et Marie Curie, 47 Blvd de l'Hôpital, 75013 Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · INSERM U1127, Institut du Cerveau et de la Moelle Épinière (ICM), Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France . · CATI multicenter neuroimaging platform (cati-neuroimaging.com), Paris, France . · IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli, Brescia, Italy. · Inserm, U1127, F-75013, Paris, France. · CNRS, UMR 7225 ICM, 75013, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France. · Institut du Cerveau et de la Moelle Épinière, ICM, F-75013, Paris, France. · Inria, Aramis project-team, Centre de Recherche Paris-Rocquencourt, France. · AXA Research Fund & UPMC, Paris, France. · Department of Neuropsychology, Hôpital Neurologique Pierre Wertheimer, Lyon, France. · Hôpital Neurologique Pierre Wertheimer, Lyon, France. · CHRU, Gui de Chauliac, Montpellier, France. · Centre Mémoire/Centre de Recherche Clinique-Gérontopôle, Hôpital Casselardit, Toulouse, France. · Hôpital General, Dijon, France. · Lyon 1 University, Hospices Civils de Lyon, Hôpital neurologique, Service de Neurologie D, Lyon, France. · Université de Lille, Inserm U1171, CHU, Centre Mémoire, 59000, Lille, France. · Université de Lille, Inserm U1171, Service de Neuroradiologie, Hôpital Roger Salengro, Lille, France. · Hôpital de la Timone, Marseille, France. · CENIR, Neuroimaging Unit, ICM, Hôpital de la Salpêtriere, Paris, France. · Eisai SAS, La Defense 2 Cedex, France. · Neurologie de la Mémoire et du Langage, Université Paris Descartes, Sorbonne Paris Cité, INSERM UMR S894, Centre Hospitalier Sainte Anne, Paris, France. · Neuroradiology Department, Hôpital de la Salpêtriere, Paris, France. · Pubmed 27780331
  • Department of Neurology, Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence 'Démences Rares', Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; Department of Neurology, University of Cagliari, Cagliari, Italy. · Service de Médecine Nucléaire, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; Université Pierre et Marie Curie-Paris 6, INSERM, UMR-S 678, Paris, France. · Service de Médecine Nucléaire, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · Department of Metabolic Biochemistry, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), ICM-INSERM 1127, FrontLab, Paris, France. · Department of Neurology, Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence 'Démences Rares', Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), ICM-INSERM 1127, FrontLab, Paris, France. · Department of Neurology, Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence 'Démences Rares', Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), ICM-INSERM 1127, FrontLab, Paris, France. Electronic address: · Pubmed 26988428
2015
  • AXA Research Fund & UPMC Chair, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC), Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) & Institut du Cerveau et de la Moelle épinière (ICM), UMR S 1127, Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France. · Alzheimers Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Barcelona, Spain. · Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · CATI Multicenter Neuroimaging Platform, France. · Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Istituto Centro "San Giovanni diDio-Fatebenefratelli", Brescia, Italy. · Inserm, U1157, Lille, France. · Université de Lille, Lille, France. · Institut Pasteur de Lille, Lille, France. · Centre Hospitalier Régional Universitaire de Lille, Lille, France. · Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany & German Center forNeurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, Germany. · Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, University Hospital of "Tor Vergata", Rome, Italy. · Department of Biomedicine and Prevention University of Rome "Tor Vergata", Rome, Italy. · Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Sorbonne Universités, UPMC Univ Paris 06, Inserm U 1146, CNRS UMR 7371, Laboratoire d'Imagerie Biomédicale, Paris, France. · AP-HP, Pitié-Salpêtrière Hospital, Nuclear Medicine Department, Paris, France. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · The Torsten Söderberg Professorship in Medicine at the Royal Swedish Academy of Sciences. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Institute for Aging and Alzheimer's Disease Research & Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA. · Cognitive Systems Group, Discipline of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland. · Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland. · President, Federal Institute of Drugs and Medical Devices (BfArM), Bonn, Germany. · Institute of Brain, Behaviours and Mental Health, University of Manchester, Manchester, UK. · IM2A - Institute of Memory and Alzheimer's Disease, IHU-A-ICM - Paris Institute of Translational Neurosciences, Pitié-Salpêtrière University Hospital, Paris, France. · Department of Psychiatry, University of Cologne, Cologne, Germany. · German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. · Medical & Scientific Relations, Alzheimer's Association, Chicago, IL, USA. · Department of Neurosciences, University of California, San Diego, San Diego, CA, USA∥ · Pubmed 26402088
  • AXA Research Fund & UPMC Chair, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) & Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, Paris, France. · Institute for Aging and Alzheimer's Disease Research & Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Centre Mémoire de Ressources et de Recherche (CMRR) Paris Nord Ile-de-France, Groupe Hospitalier Saint Louis Lariboisière - Fernand Widal, Université Paris Diderot, Paris 07, Paris, France. · Institut du Fer à Moulin (IFM), Inserm UMR_S 839, Paris, France. · University College London Institute of Neurology, Queen Square, London, UK. · Pubmed 26401553
  • S. Lista, Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) and Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, Paris, France, · Pubmed 25651440
  • Institute for Aging & Alzheimer's Disease Research and Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA. Electronic address: sid.o' · Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical Sciences, Edith Cowan University, Joondalup, WA, Australia. · Nordic Bioscience Biomarkers and Research, Neurodegenerative Diseases, Herlev, Denmark. · Department of Psychology, University of North Texas, Denton, TX, USA. · Quanterix, Inc., Lexington, MA, USA. · AXA Research Fund & UPMC Chair, Paris, France. · Department of Old Age Psychiatry, King's College London, Institute of Psychiatry, London, UK. · Bristol-Myers Squibb, Wallingford, CT, USA. · AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut dela Mémoire et de la Maladie d'Alzheimer (IM2A) & Institut du Cerveau et dela Moelle épinière (ICM), Département de Neurologie, Hôpital de laPitié- Salpétrière, Paris, France; Département de Neurologie, Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière, Paris, France. · Department of Pathology, University of Washington, Seattle, WA, USA. · Clinical Neurochemistry Laboratory, Department of Neuroscience and Physiology, University of Goteborg, Sahlgrenska University Hospital, Molndal, Sweden. · Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA. · Alzheimer's Association, Chicago, IL, USA. · Department of Neurology, Mayo Clinic Jacksonville, Jacksonville, FL, USA. · Department of Neurodegeneration, Center of Neurology, Section for Dementia Research, Hertie-Institute of Clinical Brain Research, University of Tubingen, Tubingen, Germany. · Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Epidemiology, Joseph P Mailman School of Public Health, Columbia University, New York, NY, USA. · Alzheimer's Disease Cooperative Study, Department of Neurosciences, UCSD School of Medicine, La Jolla, CA, USA. · Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA. · Meso Scale Discovery, Rockville, MD, USA. · Department of Medicine, Radiology and Psychiatry, University of California, San Francisco, CA, USA. · Texas Tech University Health Science Center, Garrison Institute on Aging, Lubbock, TX, USA. · Pfizer Inc., New York, NY, USA. · Pubmed 25282381
  • AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · ICM, CNRS UMR 7225, Inserm U 1127, UPMC-P6 UMR S 1127, GH Pitié-Salpêtrière, 47 Bd de l'Hôpital, Paris, France. · INSERM U1027, Toulouse, France. · Faculté de Médecine Université Toulouse III, Toulouse, France. · Department of Epidemiology and Public Health, Toulouse University Hospital, Toulouse, France. · Department of Internal Medicine and Geriatrics, CHU Toulouse, Toulouse, France. · Gérontopole, Toulouse University Hospital, Toulouse, France. · AXA Research Fund & UPMC Chair, Paris, France. · IHU-A-ICM - Paris Institute of Translational Neurosciences, Hôpital de la Pitié-Salpêtrière, Paris, France. · Pubmed 26402073
  • Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilian-University, Munich, Bayern, Germany. Electronic address: · Department of Radiology, University of California San Francisco, San Francisco, CA, USA; Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden. · Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden; Neuropsychiatric Clinic, Malmö University Hospital, Malmö, Sweden. · Alzheimer's disease and other cognitive disorders unit, Neurology Service, ICN Hospital Clinic i Universitari and Pasqual Maragall Foundation, Barcelona, Spain. · Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Nordrhein-Westfalen, Germany; Department of Psychiatry, University Hospital of Lausanne, Lausanne, Waadt, Switzerland. · Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Nordrhein-Westfalen, Germany. · Department of Neurology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland. · Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany. · Department of Psychiatry and Psychotherapy, University Hospital, Tübingen, Germany. · Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilian-University, Munich, Bayern, Germany. · Center of Old Age Psychiatry, Psychiatric University Hospital, Basel, Switzerland. · Department of Biological Regulation, School of Health Science, Tottori University Faculty of Medicine, Yonago, Japan. · AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer & Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer & Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, Paris, France. · Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden. · Pubmed 25804998
  • Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France. Electronic address: · INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France. · Hôpital Neurologique Pierre Wertheimer, Lyon, France. · CHRU, Gui de Chauliac, Montpellier, France. · Hôpital Casselardit, Toulouse, France. · Clinique Pasteur, Toulouse, France. · Hôpital Général, Dijon, France. · CHRU, Clinique de Neurologie, Univ Lille Nord de France UDSL, EA1046, Lille, France. · Hôpital Roger Salengro, Lille, France. · Hôpital de la Timone, Marseille, France. · Centre INSERM U897-Epidemiologie & Biostatistique, Université de Bordeaux, Bordeaux, France. · INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France; CENIR, Neuroimaging Unit, ICM, Hôpital de la Salpêtrière, Paris, France. · Eisai SAS, La Defense 2 Cedex, Paris, France. · INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France; Neuroradiology Department, Hôpital de la Salpêtrière, Paris, France. · Pubmed 25596420
2014
  • Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Pavillon François Lhermitte, Hôpital de la Salpêtrière, Université Pierre et Marie Curie, 47 Boulevard de l'Hôpital, 75013, Paris, France, · Pubmed 24807087
  • Center for Advanced Therapeutic Strategies for Brain Disorders, The Roskamp Institute, Sarasota, FL, USA Department of Neurology, Xiangya Hospital, Central South University, Changsha, China. · Department of Psychiatry and Psychotherapy, Alzheimer Memorial Center, University of Munich, Munich, Germany Université Pierre et Marie Curie, Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer, Hôpital de la Salpêtrière, Paris, France. · Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Sahlgren's University Hospital, Mölndal, Sweden. · Université Pierre et Marie Curie, Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer, Hôpital de la Salpêtrière, Paris, France. · Department of Neurology and Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA. · Department of Neurology, Xiangya Hospital, Central South University, Changsha, China. · Department of Neurology, Xiangya Hospital, Central South University, Changsha, China Center for Hormone Advanced Science and Education, Roskamp Institute, Sarasota, FL, USA. · Center for Advanced Therapeutic Strategies for Brain Disorders, The Roskamp Institute, Sarasota, FL, USA Department of Neurology, Xiangya Hospital, Central South University, Changsha, China Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA. · Pubmed 24685635
2015
Probable:    INSERM France      
2018
  • AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013 Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013 Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013 Paris, France. Electronic address: · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013 Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013 Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013 Paris, France. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Department of Neurology, College of Medicine, Hanyang University, Seoul, Republic of Korea; Cell Therapy Center, Hanyang University Hospital, Seoul, Republic of Korea. · Breast and Menopause Clinic, Ghent University Hospital, Corneel Heymanslaan 10, B-9000 Ghent, Belgium. · Department of Physiology and Pharmacology "Vittorio Erspamer", University of Rome "Sapienza", Rome, Italy. · Neuropharmacology Lab, European Brain Research Institute (E.B.R.I.), Rome, Italy. · Neuropharmacology Lab, European Brain Research Institute (E.B.R.I.), Rome, Italy; Department of Biology, University of Rome "Tor Vergata", Rome, Italy. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013 Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013 Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013 Paris, France. Electronic address: · Pubmed 29902481
  • AXA Research Fund & Sorbonne Université Chair, Paris, France. · Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Boulevard de l'hôpital, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy. · Department of Radiology, "Athinoula A. Martinos" Center for Biomedical Imaging, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Department of Physiology and Pharmacology "Vittorio Erspamer", University of Rome "La Sapienza", Rome, Italy. · Institute for Research and Medical Care, IRCCS "San Raffaele Pisana", Rome, Italy. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Department of Neurosurgery, Maxine Dunitz Neurosurgical Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience (TCIN), Trinity College Dublin, Dublin, Ireland. · Unit of Neurosurgery, Azienda Ospedaliera Universitaria Senese, Siena, Italy. · IRCCS "San Giovanni di Dio-Fatebenefratelli", Brescia, Italy. · Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM) Paris, France; Inria, Aramis project-team, Centre de Recherche de Paris, France; Department of Neuroradiology, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France; Department of Neurology, AP-HP, Hôpital de la Pitié-Salpêtrière, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Paris, France. · Sorbonne Université, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM) Paris, France; Inria, Aramis project-team, Centre de Recherche de Paris, France. · IREM, Institute for Regenerative Medicine, University of Zurich, Zürich, Switzerland. · ZNZ Neuroscience Center Zurich, Zürich, Switzerland. · Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Inserm U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle Épinière, ICM, Ecole Normale Supérieure, ENS, Centre MEG-EEG, Paris, France. · Département de Médecine Nucléaire, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · Laboratoire d'Imagerie Biomédicale, Sorbonne Universités, UPMC Univ Paris 06, Inserm U 1146, CNRS UMR 7371, Paris, France. · Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK. · Division of Informatics, Imaging and Data Sciences, University of Manchester, Wolfson Molecular Imaging Centre, Manchester, UK. · Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Functional Neuromodulation, Ltd., Boston, MA, USA. · Centre de NeuroImagerie de Recherche - CENIR, Institut du Cerveau et de la Moelle Épinière - ICM, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Inserm U 1127, CNRS UMR 7225, ICM, Paris, France. · Institut de la Vision, INSERM, Sorbonne Universités, UPMC Univ Paris 06, UMR_S968, CNRS UMR7210, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, CNRS UMR 8256, Institut de Biologie Paris-Seine (IBPS), Place Jussieu, Paris, France. · Department of Biology, University of Rome "Tor Vergata" & Pharmacology of Synaptic Disease Lab, European Brain Research Institute (E.B.R.I.), Rome, Italy. · Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. · Department of Medicine, Surgery and Neurosciences, Unit of Neurology and Clinical Neurophysiology, Brain Investigation & Neuromodulation Lab. (Si-BIN Lab.), University of Siena, Siena, Italy. · Department of Medicine, Surgery and Neurosciences, Section of Human Physiology University of Siena, Siena, Italy. · Berenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. · Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA. · IU Network Science Institute, Indiana University, Bloomington, IN, USA. · NeuroVision Imaging LLC, Sacramento, CA, USA. · ITTM Solutions, Esch-sur-Alzette, Luxembourg. · Casa di Cura "San Raffaele Cassino", Cassino, Italy. · Pubmed 29562524
  • AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Department of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada. · Biostatistics and Special Pharmacokinetics Unit/Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Health Affairs CEO, UCI Health, University of California, Irvine, CA, USA. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Neurological Surgery, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Anatomy & Neurobiology, University of California Irvine School of Medicine, Irvine, CA, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Neurology/Psychiatry/Ophthalmology Unit, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Foundational Neuroscience Center (FNC), AbbVie Neuroscience, Cambridge, MA, USA; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK; Institute of Neurodegenerative Diseases, Catholic University of Leuven, Leuven, Belgium. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA. · College of Sciences, One UTSA Circle, The University of Texas at San Antonio, San Antonio, TX, USA. · Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. · Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. · Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · Pubmed 29458203
  • Genetadi Biotech S.L. Parque Tecnológico de Bizkaia, Derio, Bizkaia, Spain. · AXA Research Fund & UPMC Chair, F-75013, Paris, France. · Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. · Pubmed 29512064
  • AXA Research Fund & Sorbonne Université Chair, Paris, France; Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Department of Radiology, "Athinoula A. Martinos" Center for Biomedical Imaging, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · AXA Research Fund & Sorbonne Université Chair, Paris, France; Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK; UK Dementia Research Institute, London, UK. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Psychosomatic Medicine, University of Rostock & DZNE Rostock, Rostock, Germany. · AXA Research Fund & Sorbonne Université Chair, Paris, France; Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France; IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Casa di Cura "San Raffaele Cassino", Cassino, Italy. · Pubmed 29328927
  • Neurodegenerative Disorder Research Center and Brain Bank, Material Science at Microscale National Laboratory, School of Life Sciences, Key Laboratory of Brain Function and Disease, Chinese Academy of Sciences, University of Science and Technology of China, Hefei; Center for Advanced, Therapeutic Strategies for Brain Disorders, Sarasota; Department of Neurology, University of Florida College of Medicine, Gainesville, Florida. · Roskamp Institute, Sarasota. · Memory Center, Sarasota. · Department of Economics, Arizona State University, Tempe, Arizona. · Paris Institute of Translational Neurosciences IHU-A-ICM, Pitié-Salpêtrière University Hospital; AXA Research Fund & Université Pierre et Marie Curie Chair, Sorbonne Universités, Université Pierre et Marie Curie Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle. · Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen; Center of Old Age Psychiatry, Psychiatric University Hospital, Basel, Switzerland. · Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen. · Department of Psychiatry and Psychotherapy, Alzheimer Memorial Center, Ludwig-Maximilian University, Munich, Germany. · Department of Neurology and Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, Georgia. · Department of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden. · Beijing Anding Hospital, Capital Medical University & Beijing Key Laboratory of Mental Disorders, Beijing; Beijing Institute for Brain Disorders, Beijing, China; Center for Hormone Advanced Science and Education, Sarasota. Electronic address: · Paris Institute of Translational Neurosciences IHU-A-ICM, Pitié-Salpêtrière University Hospital; AXA Research Fund & Université Pierre et Marie Curie Chair, Sorbonne Universités, Université Pierre et Marie Curie Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle; Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer, Hôpital Pitié-Salpêtrière, Paris, France. · Pubmed 28359566
2017
  • AXA Research Fund & UPMC Chair, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et dela moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), HôpitalPitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX, USA. · The Torsten Söderberg Professorship in Medicine at the Royal Swedish Academy of Sciences, Stockholm, Sweden. · AXA Research Fund & UPMC Chair, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) & Institut du Cerveau et de la Moelle Épinière (ICM), Paris, France; Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Pubmed 28508359
  • a AXA Research Fund & UPMC Chair , Paris , France. · b Département de Neurologie , Sorbonne Universités, Université Pierre et Marie Curie (UPMC), Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital , Paris , France. · c Institute for Healthy Aging , University of North Texas Health Science Center , Fort Worth , TX , USA. · d ARAMIS Lab, Inria Paris , Paris , France. · e Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, Institut du cerveau et la moelle (ICM), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital , Paris , France. · f European Society for Translational Medicine , Vienna , Austria. · g Medical Research Council Centre for Neuropsychiatric Genetics and Genomics , Cardiff University , Cardiff , UK. · h Département de Neurologie , Sorbonne Université, Université Pierre et Marie Curie, Paris 06 UMR S 1127, Institut National de Santé et en Recherche Médicale (INSERM) U 1127 and CIC-1422, Centre National de Recherche Scientifique U 7225, Institut du Cerveau et de la Moelle Epinière, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière , Paris , France. · i President, Federal Institute for Drugs and Medical Devices (BfArM) , Bonn , Germany. · Pubmed 28286989
  • a Department of Clinical and Experimental Medicine , University of Pisa , Pisa , Italy. · b AXA Research Fund UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie , Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital , Paris , France. · c IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli , Brescia , Italy. · Pubmed 28281838
  • AXA Research Fund and UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · IRCCS Centro San Giovanni di Dio, Brescia, Italy. · Department of Nuclear Medicine, Charité- Universitätsmedizin Berlin, Berlin, Germany. · Jung diagnostics GmbH, Hamburg, Germany. · Eli Lilly and Company, Indianapolis, IN, USA. · Department of Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28777748
  • AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Department of Radiology, "Athinoula A. Martinos" Center for Biomedical Imaging, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; The Torsten Söderberg Professorship in Medicine at the Royal Swedish Academy of Sciences, Sweden. · Department of Psychosomatic Medicine, University of Rostock & DZNE Rostock, Rostock, Germany. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France; IRCCS "San Giovanni di Dio-Fatebenefratelli", Brescia, Italy. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Casa di Cura "San Raffaele Cassino", Cassino, Italy. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Pubmed 28527630
  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy; Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Psychosomatic Medicine, University of Rostock and DZNE, Rostock, Germany. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France; AXA Research Fund & UPMC Chair, Paris, France; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. · Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy; Casa di Cura "San Raffaele Cassino", Cassino, Frosinone, Italy. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. Electronic address: · Pubmed 28263742
2016
  • German Center for Neurodegenerative Diseases (DZNE) - Rostock/Greifswald, Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. Electronic address: · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; INSERM U1127, Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France; Sorbonne Universites, Universite Pierre et Marie Curie-Paris 6, Paris, France; CATI Multicenter Neuroimaging Platform, France; IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli, Italy. · German Center for Neurodegenerative Diseases (DZNE) - Rostock/Greifswald, Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; INSERM U1127, Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France; Sorbonne Universites, Universite Pierre et Marie Curie-Paris 6, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. · IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli, Italy. · Inserm, U1127, F-75013, Paris, France; CNRS, UMR 7225 ICM, 75013, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France; Inria, Aramis Project-team, Centre de Recherche Paris-Rocquencourt, France. · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; IHU-A-ICM - Paris Institute of Translational Neurosciences, Paris, France. · Inserm, U1127, F-75013, Paris, France; CNRS, UMR 7225 ICM, 75013, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France; Neuroradiology Department, Hôpital de la Salpêtriere, Paris, France. · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; INSERM U1127, Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France; Sorbonne Universites, Universite Pierre et Marie Curie-Paris 6, Paris, France. · Pubmed 26876309
  • Université Pierre et Marie Curie, 47 Blvd de l'Hôpital, 75013 Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · INSERM U1127, Institut du Cerveau et de la Moelle Épinière (ICM), Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France . · CATI multicenter neuroimaging platform (cati-neuroimaging.com), Paris, France . · IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli, Brescia, Italy. · Inserm, U1127, F-75013, Paris, France. · CNRS, UMR 7225 ICM, 75013, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France. · Institut du Cerveau et de la Moelle Épinière, ICM, F-75013, Paris, France. · Inria, Aramis project-team, Centre de Recherche Paris-Rocquencourt, France. · AXA Research Fund & UPMC, Paris, France. · Department of Neuropsychology, Hôpital Neurologique Pierre Wertheimer, Lyon, France. · Hôpital Neurologique Pierre Wertheimer, Lyon, France. · CHRU, Gui de Chauliac, Montpellier, France. · Centre Mémoire/Centre de Recherche Clinique-Gérontopôle, Hôpital Casselardit, Toulouse, France. · Hôpital General, Dijon, France. · Lyon 1 University, Hospices Civils de Lyon, Hôpital neurologique, Service de Neurologie D, Lyon, France. · Université de Lille, Inserm U1171, CHU, Centre Mémoire, 59000, Lille, France. · Université de Lille, Inserm U1171, Service de Neuroradiologie, Hôpital Roger Salengro, Lille, France. · Hôpital de la Timone, Marseille, France. · CENIR, Neuroimaging Unit, ICM, Hôpital de la Salpêtriere, Paris, France. · Eisai SAS, La Defense 2 Cedex, France. · Neurologie de la Mémoire et du Langage, Université Paris Descartes, Sorbonne Paris Cité, INSERM UMR S894, Centre Hospitalier Sainte Anne, Paris, France. · Neuroradiology Department, Hôpital de la Salpêtriere, Paris, France. · Pubmed 27780331
  • Department of Neurology, Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence 'Démences Rares', Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; Department of Neurology, University of Cagliari, Cagliari, Italy. · Service de Médecine Nucléaire, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; Université Pierre et Marie Curie-Paris 6, INSERM, UMR-S 678, Paris, France. · Service de Médecine Nucléaire, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · Department of Metabolic Biochemistry, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), ICM-INSERM 1127, FrontLab, Paris, France. · Department of Neurology, Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence 'Démences Rares', Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), ICM-INSERM 1127, FrontLab, Paris, France. · Department of Neurology, Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence 'Démences Rares', Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), ICM-INSERM 1127, FrontLab, Paris, France. Electronic address: · Pubmed 26988428
2015
  • Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France. Electronic address: · INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France. · Hôpital Neurologique Pierre Wertheimer, Lyon, France. · CHRU, Gui de Chauliac, Montpellier, France. · Hôpital Casselardit, Toulouse, France. · Clinique Pasteur, Toulouse, France. · Hôpital Général, Dijon, France. · CHRU, Clinique de Neurologie, Univ Lille Nord de France UDSL, EA1046, Lille, France. · Hôpital Roger Salengro, Lille, France. · Hôpital de la Timone, Marseille, France. · Centre INSERM U897-Epidemiologie & Biostatistique, Université de Bordeaux, Bordeaux, France. · INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France; CENIR, Neuroimaging Unit, ICM, Hôpital de la Salpêtrière, Paris, France. · Eisai SAS, La Defense 2 Cedex, Paris, France. · INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France; Neuroradiology Department, Hôpital de la Salpêtrière, Paris, France. · Pubmed 25596420
Probable:    Martin-Luther-Universitat Halle-Wittenberg      
2016
  • Department of Psychiatry, Psychotherapy and Psychosomatics, Martin-Luther-University Halle-Wittenberg, Julius-Kühn-Straße 7, 06112, Halle (Saale), Germany, · Pubmed 26235059
2014
  • Université Pierre et Marie Curie, Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Pavillon François Lhermitte, Hôpital de la Salpêtrière, Paris, France. Electronic address: · Department of Psychiatry, Psychotherapy and Psychosomatics, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany. Electronic address: · Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany; German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, Germany. · Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology, and Radiotherapy, University of Rome "Tor Vergata", Rome, Italy; IRCCS San Raffaele Pisana, Rome and San Raffaele Cassino, Cassino, Italy. · Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy; IRCSS Santa Lucia Foundation, Rome, Italy. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; University College London Institute of Neurology, Queen Square, London, UK. · Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. · Laboratoire de Neuropathologie Raymond-Escourolle, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France. · IM2A - Institute of Memory and Alzheimer's Disease, Paris, France; IHU-A-ICM - Paris Institute of Translational Neurosciences Pitié-Salpêtrière University Hospital, Paris, France. · Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany. · Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Épinière, UMR-S975 Paris, France; Inserm, U975, Paris, France; CNRS, UMR 7225, Paris, France; ICM - Institut du Cerveau et de la Moelle Épinière, Paris, France; INRIA, Aramis Team, Centre de Recherche Paris-Rocquencourt, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié Salpêtrière, Paris, France; Université Pierre et Marie Curie, Paris, France. · Federal Institute of Drugs and Medical Devices (BfArM), Bonn, Germany. · IHU-A-ICM - Paris Institute of Translational Neurosciences Pitié-Salpêtrière University Hospital, Paris, France; Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Épinière, UMR-S975 Paris, France; Inserm, U975, Paris, France; CNRS, UMR 7225, Paris, France; ICM - Institut du Cerveau et de la Moelle Épinière, Paris, France. · Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Épinière, UMR-S975 Paris, France; Inserm, U975, Paris, France; CNRS, UMR 7225, Paris, France; ICM - Institut du Cerveau et de la Moelle Épinière, Paris, France; AP-HP, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · The Campaign to Prevent Alzheimer's Disease by 2020 (PAD2020), Potomac, MD, USA. · Department of Neurosciences, University of California, San Diego, San Diego, CA, USA. · Pubmed 24275164
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 46 total) written by Simone Lista about Alzheimer Disease:

  • Precision medicine and drug development in Alzheimer's disease: the importance of sexual dimorphism and patient stratification. 2018
  • Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology. 2018
  • Precision pharmacology for Alzheimer's disease. 2018
  • Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials. 2018
  • Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study. 2018
  • Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ 2018
  • Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment. 2018
  • Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer's Disease. 2017
  • Evolving Relevance of Neuroproteomics in Alzheimer's Disease. 2017
  • A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling. 2017
Show List of Full Article Records
Google Searches

Learn more about Simone Lista using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Sorbonne University
INSERM France
Martin-Luther-Universitat Halle-Wittenberg
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Sorbonne University
2018
  • AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013 Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013 Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013 Paris, France. Electronic address: · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013 Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013 Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013 Paris, France. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Department of Neurology, College of Medicine, Hanyang University, Seoul, Republic of Korea; Cell Therapy Center, Hanyang University Hospital, Seoul, Republic of Korea. · Breast and Menopause Clinic, Ghent University Hospital, Corneel Heymanslaan 10, B-9000 Ghent, Belgium. · Department of Physiology and Pharmacology "Vittorio Erspamer", University of Rome "Sapienza", Rome, Italy. · Neuropharmacology Lab, European Brain Research Institute (E.B.R.I.), Rome, Italy. · Neuropharmacology Lab, European Brain Research Institute (E.B.R.I.), Rome, Italy; Department of Biology, University of Rome "Tor Vergata", Rome, Italy. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013 Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013 Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013 Paris, France. Electronic address: · Pubmed 29902481
  • AXA Research Fund & Sorbonne Université Chair, Paris, France. · Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Boulevard de l'hôpital, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy. · Department of Radiology, "Athinoula A. Martinos" Center for Biomedical Imaging, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Department of Physiology and Pharmacology "Vittorio Erspamer", University of Rome "La Sapienza", Rome, Italy. · Institute for Research and Medical Care, IRCCS "San Raffaele Pisana", Rome, Italy. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Department of Neurosurgery, Maxine Dunitz Neurosurgical Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience (TCIN), Trinity College Dublin, Dublin, Ireland. · Unit of Neurosurgery, Azienda Ospedaliera Universitaria Senese, Siena, Italy. · IRCCS "San Giovanni di Dio-Fatebenefratelli", Brescia, Italy. · Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM) Paris, France; Inria, Aramis project-team, Centre de Recherche de Paris, France; Department of Neuroradiology, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France; Department of Neurology, AP-HP, Hôpital de la Pitié-Salpêtrière, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Paris, France. · Sorbonne Université, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM) Paris, France; Inria, Aramis project-team, Centre de Recherche de Paris, France. · IREM, Institute for Regenerative Medicine, University of Zurich, Zürich, Switzerland. · ZNZ Neuroscience Center Zurich, Zürich, Switzerland. · Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Inserm U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle Épinière, ICM, Ecole Normale Supérieure, ENS, Centre MEG-EEG, Paris, France. · Département de Médecine Nucléaire, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · Laboratoire d'Imagerie Biomédicale, Sorbonne Universités, UPMC Univ Paris 06, Inserm U 1146, CNRS UMR 7371, Paris, France. · Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK. · Division of Informatics, Imaging and Data Sciences, University of Manchester, Wolfson Molecular Imaging Centre, Manchester, UK. · Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Functional Neuromodulation, Ltd., Boston, MA, USA. · Centre de NeuroImagerie de Recherche - CENIR, Institut du Cerveau et de la Moelle Épinière - ICM, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Inserm U 1127, CNRS UMR 7225, ICM, Paris, France. · Institut de la Vision, INSERM, Sorbonne Universités, UPMC Univ Paris 06, UMR_S968, CNRS UMR7210, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, CNRS UMR 8256, Institut de Biologie Paris-Seine (IBPS), Place Jussieu, Paris, France. · Department of Biology, University of Rome "Tor Vergata" & Pharmacology of Synaptic Disease Lab, European Brain Research Institute (E.B.R.I.), Rome, Italy. · Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. · Department of Medicine, Surgery and Neurosciences, Unit of Neurology and Clinical Neurophysiology, Brain Investigation & Neuromodulation Lab. (Si-BIN Lab.), University of Siena, Siena, Italy. · Department of Medicine, Surgery and Neurosciences, Section of Human Physiology University of Siena, Siena, Italy. · Berenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. · Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA. · IU Network Science Institute, Indiana University, Bloomington, IN, USA. · NeuroVision Imaging LLC, Sacramento, CA, USA. · ITTM Solutions, Esch-sur-Alzette, Luxembourg. · Casa di Cura "San Raffaele Cassino", Cassino, Italy. · Pubmed 29562524
  • AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Department of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada. · Biostatistics and Special Pharmacokinetics Unit/Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Health Affairs CEO, UCI Health, University of California, Irvine, CA, USA. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Neurological Surgery, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Anatomy & Neurobiology, University of California Irvine School of Medicine, Irvine, CA, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Neurology/Psychiatry/Ophthalmology Unit, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Foundational Neuroscience Center (FNC), AbbVie Neuroscience, Cambridge, MA, USA; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK; Institute of Neurodegenerative Diseases, Catholic University of Leuven, Leuven, Belgium. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA. · College of Sciences, One UTSA Circle, The University of Texas at San Antonio, San Antonio, TX, USA. · Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. · Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. · Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · Pubmed 29458203
  • Genetadi Biotech S.L. Parque Tecnológico de Bizkaia, Derio, Bizkaia, Spain. · AXA Research Fund & UPMC Chair, F-75013, Paris, France. · Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. · Pubmed 29512064
  • Centre des Maladies Cognitives et Comportementales, Sorbonne Université, Hôpital de la Salpêtrière, Paris, France. Electronic address: · Centre des Maladies Cognitives et Comportementales, Sorbonne Université, Hôpital de la Salpêtrière, Paris, France. · IQVIA, Saint-Ouen, France. · Institut du Cerveau et de la Moelle Epinière (ICM), Institute of Memory and Alzheimer's Disease (IM2A), Centre of Excellence of Neurodegenerative Disease (CoEN), Sorbonne Université, Hôpital de la Salpêtrière, Paris, France. · Inria ARAMIS Project Team, Department of Neuroradiology, Sorbonne Université, Hôpital de la Salpêtrière, Paris, France. · Service de Biochimie Métabolique, Sorbonne Université, Hôpital de la Salpêtrière, Paris, France. · Laboratoire d'Imagerie Biomédicale, Nuclear Medicine Department, Sorbonne Université, Hôpital de la Salpêtrière, Paris, France. · Neurospin, Institut d'Imagerie BioMédicale, Le Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Gif-sur-Yvette, France. · Pubmed 29500152
  • AXA Research Fund & Sorbonne Université Chair, Paris, France; Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Department of Radiology, "Athinoula A. Martinos" Center for Biomedical Imaging, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · AXA Research Fund & Sorbonne Université Chair, Paris, France; Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK; UK Dementia Research Institute, London, UK. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Psychosomatic Medicine, University of Rostock & DZNE Rostock, Rostock, Germany. · AXA Research Fund & Sorbonne Université Chair, Paris, France; Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France; IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Casa di Cura "San Raffaele Cassino", Cassino, Italy. · Pubmed 29328927
  • Neurodegenerative Disorder Research Center and Brain Bank, Material Science at Microscale National Laboratory, School of Life Sciences, Key Laboratory of Brain Function and Disease, Chinese Academy of Sciences, University of Science and Technology of China, Hefei; Center for Advanced, Therapeutic Strategies for Brain Disorders, Sarasota; Department of Neurology, University of Florida College of Medicine, Gainesville, Florida. · Roskamp Institute, Sarasota. · Memory Center, Sarasota. · Department of Economics, Arizona State University, Tempe, Arizona. · Paris Institute of Translational Neurosciences IHU-A-ICM, Pitié-Salpêtrière University Hospital; AXA Research Fund & Université Pierre et Marie Curie Chair, Sorbonne Universités, Université Pierre et Marie Curie Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle. · Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen; Center of Old Age Psychiatry, Psychiatric University Hospital, Basel, Switzerland. · Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen. · Department of Psychiatry and Psychotherapy, Alzheimer Memorial Center, Ludwig-Maximilian University, Munich, Germany. · Department of Neurology and Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, Georgia. · Department of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden. · Beijing Anding Hospital, Capital Medical University & Beijing Key Laboratory of Mental Disorders, Beijing; Beijing Institute for Brain Disorders, Beijing, China; Center for Hormone Advanced Science and Education, Sarasota. Electronic address: · Paris Institute of Translational Neurosciences IHU-A-ICM, Pitié-Salpêtrière University Hospital; AXA Research Fund & Université Pierre et Marie Curie Chair, Sorbonne Universités, Université Pierre et Marie Curie Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle; Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer, Hôpital Pitié-Salpêtrière, Paris, France. · Pubmed 28359566
2017
  • AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universities, Pierre and Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France. Electronic address: · AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universities, Pierre and Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France; Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universities, Pierre and Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France. · Imaging Genetics Center, Stevens Institute for Neuroimaging & Informatics, Keck School of Medicine, University of Southern California, Los Angeles, CA 90232, USA. · AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universities, Pierre and Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France. Electronic address: · Pubmed 28684173
  • AXA Research Fund & UPMC Chair, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et dela moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), HôpitalPitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX, USA. · The Torsten Söderberg Professorship in Medicine at the Royal Swedish Academy of Sciences, Stockholm, Sweden. · AXA Research Fund & UPMC Chair, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) & Institut du Cerveau et de la Moelle Épinière (ICM), Paris, France; Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Pubmed 28508359
  • a AXA Research Fund & UPMC Chair , Paris , France. · b Département de Neurologie , Sorbonne Universités, Université Pierre et Marie Curie (UPMC), Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital , Paris , France. · c Institute for Healthy Aging , University of North Texas Health Science Center , Fort Worth , TX , USA. · d ARAMIS Lab, Inria Paris , Paris , France. · e Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, Institut du cerveau et la moelle (ICM), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital , Paris , France. · f European Society for Translational Medicine , Vienna , Austria. · g Medical Research Council Centre for Neuropsychiatric Genetics and Genomics , Cardiff University , Cardiff , UK. · h Département de Neurologie , Sorbonne Université, Université Pierre et Marie Curie, Paris 06 UMR S 1127, Institut National de Santé et en Recherche Médicale (INSERM) U 1127 and CIC-1422, Centre National de Recherche Scientifique U 7225, Institut du Cerveau et de la Moelle Epinière, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière , Paris , France. · i President, Federal Institute for Drugs and Medical Devices (BfArM) , Bonn , Germany. · Pubmed 28286989
  • a Department of Clinical and Experimental Medicine , University of Pisa , Pisa , Italy. · b AXA Research Fund UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie , Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital , Paris , France. · c IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli , Brescia , Italy. · Pubmed 28281838
  • AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; ICM, CNRS UMR 7225, Inserm U 1127, UPMC-P6 UMR S 1127, GH Pitié-Salpêtrière, Paris, France. Electronic address: · AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · ICM, CNRS UMR 7225, Inserm U 1127, UPMC-P6 UMR S 1127, GH Pitié-Salpêtrière, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de médecine nucléaire, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratoire de Biochimie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; ICM, CNRS UMR 7225, Inserm U 1127, UPMC-P6 UMR S 1127, GH Pitié-Salpêtrière, Paris, France. · AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; IHU-A-ICM, Paris Institute of Translational Neurosciences, Hôpital de la Pitié-Salpêtrière, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. · AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; ICM, CNRS UMR 7225, Inserm U 1127, UPMC-P6 UMR S 1127, GH Pitié-Salpêtrière, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. · Pubmed 28188032
  • a AXA Research Fund & UPMC Chair , Paris , France. · b IHU-A-ICM - Paris Institute of Translational Neurosciences , Pitié-Salpêtrière University Hospital , Paris , France. · c Department of Neurology, Sorbonne Universities, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Pitié-Salpêtrière University Hospital , Pierre and Marie Curie University , Paris 06, Paris , France. · Pubmed 27332958
  • AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Hopital Pitié-Salpêtrière, Paris, France. · Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · German Center for Neurodegenerative Diseases (DZNE) - Rostock/Greifswald, Rostock, Germany. · Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. · Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, Institut du cerveau et la moelle (ICM), APHP- Hôpital Pitié-Salpêtrière, Paris, France. · Inria, Aramis project-team, Centre de Recherche de, Paris, France. · AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Hopital Pitié-Salpêtrière, Paris, France. · CATI - Centre d'Acquisition et de Traitement des Images, Paris, France. · AP-HP, Neuroradiology Department, Hôpital de la Pitié-Salpêtrière, Paris, France. · Institute of Memory and Alzheimer's Disease (IM2A), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Pitié-Salpêtrière, University Paris 6, Paris, France. · CENIR, Hôpital de la Salpêtriere, Paris, France. · INSERM U1127, Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France. · Sorbonne Universites, Universite Pierre et Marie Curie-Paris 6, Paris, France. · Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Hopital Pitié-Salpêtrière, Paris, France. · AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Hopital Pitié-Salpêtrière, Paris, France. · Pubmed 28916821
  • Department of Neurology, Institute of Memory and Alzheimer's Disease, Pitié-Salpêtrière University Hospital, Paris, France. · AXA Research Fund and UPMC Chair, Paris, France. · Department of Nuclear Medicine, Charité, Berlin, Germany. · Jung diagnostics GmbH, Hamburg, Germany. · Department of Neurology, Institute of Memory and Alzheimer's Disease, National Reference Center for Rare Dementias, Pitié Salpêtrière University Hospital, Paris, France. · Brain and Spine Institute (ICM) - INSERM 1127, Frontlab, Paris, France. · Pubmed 28869481
  • AXA Research Fund and UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · IRCCS Centro San Giovanni di Dio, Brescia, Italy. · Department of Nuclear Medicine, Charité- Universitätsmedizin Berlin, Berlin, Germany. · Jung diagnostics GmbH, Hamburg, Germany. · Eli Lilly and Company, Indianapolis, IN, USA. · Department of Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28777748
  • AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Department of Radiology, "Athinoula A. Martinos" Center for Biomedical Imaging, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; The Torsten Söderberg Professorship in Medicine at the Royal Swedish Academy of Sciences, Sweden. · Department of Psychosomatic Medicine, University of Rostock & DZNE Rostock, Rostock, Germany. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France; IRCCS "San Giovanni di Dio-Fatebenefratelli", Brescia, Italy. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Casa di Cura "San Raffaele Cassino", Cassino, Italy. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Pubmed 28527630
  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy; Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Psychosomatic Medicine, University of Rostock and DZNE, Rostock, Germany. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France; AXA Research Fund & UPMC Chair, Paris, France; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. · Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy; Casa di Cura "San Raffaele Cassino", Cassino, Frosinone, Italy. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. Electronic address: · Pubmed 28263742
  • Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX, USA. Electronic address: · Department of Neurology, Mayo Clinic, Rochester, MN, USA; Department of Health Science Research, Mayo Clinic, Rochester, MN, USA. · Alzheimer's Disease Cooperative Study, Department of Neurosciences, UCSD School of Medicine, La Jolla, CA, USA. · AXA Research Fund and UPMC Chair, Paris, France; Department de Neurologie, Institut de la Memorie et de la Maladie d'Alzheimer (IM2A) et Institut du Cerveau et du la Moelle epiniere (ICM), Hospital de la Pitie-Salpetriere, Sorbonne Universites, Universite Pierre et Marie Curie, Paris, France. · ADx NeuroSciences NV, Ghent, Belgium. · Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gotenburg, Molndal, Sweden; UCL Institute of Neurology, London, UK. · Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany; Department of Neurodegeneration Diagnostics, Medical University of Bialystok, Bialystok, Poland. · Pfizer, Inc., New York, USA. · Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX, USA. · Johnson & Johnson, London Innovation Center, London, UK. · Neuroscience Clinical Development, Clinical Neuroscience Eisai, Woodcliff Lake, NJ, USA. · Quanterix Corporation, Lexington, MA, USA. · Roche Diagnostics International Ltd., Rotkreuz, Switzerland. · Centro de Neurociencias y Unidad de Investigacion Clinica, Instituto de Investigaciones Cientificas y Servicios de Alta Tecnologia (INDICASAT AIP), Ciudad del Saber, Panama, Panama. · Department of Neurology, Rhode Island Hospital and Alpert Medical School of Brown University, Providence, RI, USA. · Neurodegenerative Diseases, Nordic Bioscience Biomarkers and Research, Herlev, Denmark. · George and Anne Ryan Institute for Neuroscience, University of Rhode Island, RI, USA. · Faculty of Health, Engineering and Sciences, Center of Excellence for Alzheimer's Disease Research and Care, School of Medical Sciences, Edith Cowan University, Joondalup, WA, Australia. · Pubmed 27870940
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal Hospital, 43180, Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal Hospital, 43180, Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Neuropsychiatry, Skaraborg Hospital, Falköping, Sweden. · Institute of Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. · Department of Endocrinology, Skaraborg Hospital, 541 85, Skövde, Sweden. · AXA Research Fund & UPMC Chair, Paris, France. · IHU-A-ICM-Paris Institute of Translational Neurosciences, Pitié-Salpêtrière University Hospital, Paris, France. · Sorbonne Universities, Pierre and Marie Curie University, Paris 06, Institute of Memory and Alzheimer's Disease (IM2A) & Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Pitié-Salpêtrière University Hospital, Paris, France. · Department of Pathology, Haartman Institute, University of Helsinki, Helsinki, Finland. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, WC1N1PJ, UK. · Pubmed 27646979
2016
  • Institute of Memory and Alzheimer's Disease (IM2A) and Brain and Spine Institute (ICM) UMR S 1127 Frontlab, Department of Neurology, AP_HP, Pitié-Salpêtrière University Hospital, Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Paris, France. Electronic address: · Institute of Memory and Alzheimer's Disease (IM2A) and Brain and Spine Institute (ICM) UMR S 1127 Frontlab, Department of Neurology, AP_HP, Pitié-Salpêtrière University Hospital, Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. · University of British Columbia, Canada. · Department of Neurology and Alzheimer Center, VU University Medical Center and Neuroscience Campus, Amsterdam, The Netherlands. · University of Southern California San Diego, CA, USA. · UMR1027, INSERM, Université Toulouse III, Toulouse University Hospital, France. · IHU-A-ICM-Institut des Neurosciences translationnelles de Paris, Paris, France. · INSERM U1146-CNRS UMR 7371-UPMC UM CR2, Site Pitié-Salpêtrière, Paris, France. · Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), Institutes of Neurogenetics and Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; School of Public Health, Faculty of Medicine, Imperial College London, London, UK. · Clinical Neurochemistry Lab, Department of Neuroscience and Physiology, University of Gothenburg, Mölndal Hospital, Sahlgrenska University Hospital, Mölndal, Sweden. · Federal Institute for Drugs and Medical Devices, Bonn, Germany. · AXA Research Fund & UPMC Chair, Paris, France; Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK. · INSERM U 1219, Université de Bordeaux, France. · University Pierre et Marie Curie, Assistance Publique des Hôpitaux de Paris, Alzheimer-Prion Team Institut du Cerveau et de la Moelle (ICM), Paris, France. · Institute of Memory and Alzheimer's Disease (IM2A) and Brain and Spine Institute (ICM) UMR S 1127 Frontlab, Department of Neurology, AP_HP, Pitié-Salpêtrière University Hospital, Sorbonne Universities, Pierre et Marie Curie University, Paris 06, Paris, France. · University Hospitals and University of Geneva, Geneva, Switzerland; IRCCS Fatebenefratelli, Brescia, Italy. · McGill Center for Studies in Aging, Douglas Mental Health Research Institute, Montreal, Canada. · Fondation pour la Recherche sur Alzheimer, Hôpital Pitié-Salpêtrière, Paris, France. · UMR1027, INSERM, Université Toulouse III, Toulouse University Hospital, France; Department of Clinical Neurophysiology/MEG Center, VU University Medical Center, Amsterdam. · Sorbonne Universités, UPMC Univ Paris 06, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, Paris, France; AP-HP, Hôpital Pitié-Salpêtrière, Département de Médecine Nucléaire, Paris, France. · Department of Neurology, Washington University, Hope Center for Neurological Disorders, St. Louis, MO, USA; Department of Neurology, Washington University, Knight Alzheimer's Disease Research Center, St. Louis, MO, USA. · Center for Alzheimer Research, Karolinska Institutet, Department of Geriatric Medicine, Karolinska University Hospital, Stockholm, Sweden; Institute of Clinical Medicine/ Neurology, University of Eastern Finland, Kuopio, Finland. · AXA Research Fund & UPMC Chair, Paris, France. · Alzheimer's Disease and Other Cognitive Disorders Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Barcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain. · Center for Alzheimer's & Neurodegenerative Disease Research, University of North Texas Health Science Center, TX, USA. · Memory & Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, USA. · Department of Molecular Imaging, Austin Health, University of Melbourne, Australia. · Memory and Aging Program, Butler Hospital, Alpert Medical School of Brown University, USA; Department of Neurology, Alpert Medical School of Brown University, USA; Department of Psychiatry, Alpert Medical School of Brown University, USA. · Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. · Harvard Medical School, Memory Disorders Unit, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Boston, USA; Harvard Medical School, Memory Disorders Unit, Center for Alzheimer Research and Treatment, Massachusetts General Hospital, Boston, USA. · The Alzheimer's Association Division of Medical & Scientific Relations, Chicago, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Department of Radiology, Mayo Clinic, Rochester MN, USA. · Pubmed 27012484
  • German Center for Neurodegenerative Diseases (DZNE) - Rostock/Greifswald, Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. Electronic address: · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; INSERM U1127, Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France; Sorbonne Universites, Universite Pierre et Marie Curie-Paris 6, Paris, France; CATI Multicenter Neuroimaging Platform, France; IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli, Italy. · German Center for Neurodegenerative Diseases (DZNE) - Rostock/Greifswald, Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; INSERM U1127, Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France; Sorbonne Universites, Universite Pierre et Marie Curie-Paris 6, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. · IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli, Italy. · Inserm, U1127, F-75013, Paris, France; CNRS, UMR 7225 ICM, 75013, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France; Inria, Aramis Project-team, Centre de Recherche Paris-Rocquencourt, France. · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; IHU-A-ICM - Paris Institute of Translational Neurosciences, Paris, France. · Inserm, U1127, F-75013, Paris, France; CNRS, UMR 7225 ICM, 75013, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France; Neuroradiology Department, Hôpital de la Salpêtriere, Paris, France. · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; INSERM U1127, Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France; Sorbonne Universites, Universite Pierre et Marie Curie-Paris 6, Paris, France. · Pubmed 26876309
  • Université Pierre et Marie Curie, 47 Blvd de l'Hôpital, 75013 Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · INSERM U1127, Institut du Cerveau et de la Moelle Épinière (ICM), Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France . · CATI multicenter neuroimaging platform (cati-neuroimaging.com), Paris, France . · IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli, Brescia, Italy. · Inserm, U1127, F-75013, Paris, France. · CNRS, UMR 7225 ICM, 75013, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France. · Institut du Cerveau et de la Moelle Épinière, ICM, F-75013, Paris, France. · Inria, Aramis project-team, Centre de Recherche Paris-Rocquencourt, France. · AXA Research Fund & UPMC, Paris, France. · Department of Neuropsychology, Hôpital Neurologique Pierre Wertheimer, Lyon, France. · Hôpital Neurologique Pierre Wertheimer, Lyon, France. · CHRU, Gui de Chauliac, Montpellier, France. · Centre Mémoire/Centre de Recherche Clinique-Gérontopôle, Hôpital Casselardit, Toulouse, France. · Hôpital General, Dijon, France. · Lyon 1 University, Hospices Civils de Lyon, Hôpital neurologique, Service de Neurologie D, Lyon, France. · Université de Lille, Inserm U1171, CHU, Centre Mémoire, 59000, Lille, France. · Université de Lille, Inserm U1171, Service de Neuroradiologie, Hôpital Roger Salengro, Lille, France. · Hôpital de la Timone, Marseille, France. · CENIR, Neuroimaging Unit, ICM, Hôpital de la Salpêtriere, Paris, France. · Eisai SAS, La Defense 2 Cedex, France. · Neurologie de la Mémoire et du Langage, Université Paris Descartes, Sorbonne Paris Cité, INSERM UMR S894, Centre Hospitalier Sainte Anne, Paris, France. · Neuroradiology Department, Hôpital de la Salpêtriere, Paris, France. · Pubmed 27780331
  • Department of Neurology, Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence 'Démences Rares', Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; Department of Neurology, University of Cagliari, Cagliari, Italy. · Service de Médecine Nucléaire, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; Université Pierre et Marie Curie-Paris 6, INSERM, UMR-S 678, Paris, France. · Service de Médecine Nucléaire, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · Department of Metabolic Biochemistry, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), ICM-INSERM 1127, FrontLab, Paris, France. · Department of Neurology, Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence 'Démences Rares', Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), ICM-INSERM 1127, FrontLab, Paris, France. · Department of Neurology, Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence 'Démences Rares', Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), ICM-INSERM 1127, FrontLab, Paris, France. Electronic address: · Pubmed 26988428
2015
  • AXA Research Fund & UPMC Chair, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC), Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) & Institut du Cerveau et de la Moelle épinière (ICM), UMR S 1127, Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France. · Alzheimers Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Barcelona, Spain. · Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · CATI Multicenter Neuroimaging Platform, France. · Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Istituto Centro "San Giovanni diDio-Fatebenefratelli", Brescia, Italy. · Inserm, U1157, Lille, France. · Université de Lille, Lille, France. · Institut Pasteur de Lille, Lille, France. · Centre Hospitalier Régional Universitaire de Lille, Lille, France. · Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany & German Center forNeurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, Germany. · Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, University Hospital of "Tor Vergata", Rome, Italy. · Department of Biomedicine and Prevention University of Rome "Tor Vergata", Rome, Italy. · Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Sorbonne Universités, UPMC Univ Paris 06, Inserm U 1146, CNRS UMR 7371, Laboratoire d'Imagerie Biomédicale, Paris, France. · AP-HP, Pitié-Salpêtrière Hospital, Nuclear Medicine Department, Paris, France. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · The Torsten Söderberg Professorship in Medicine at the Royal Swedish Academy of Sciences. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Institute for Aging and Alzheimer's Disease Research & Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA. · Cognitive Systems Group, Discipline of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland. · Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland. · President, Federal Institute of Drugs and Medical Devices (BfArM), Bonn, Germany. · Institute of Brain, Behaviours and Mental Health, University of Manchester, Manchester, UK. · IM2A - Institute of Memory and Alzheimer's Disease, IHU-A-ICM - Paris Institute of Translational Neurosciences, Pitié-Salpêtrière University Hospital, Paris, France. · Department of Psychiatry, University of Cologne, Cologne, Germany. · German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. · Medical & Scientific Relations, Alzheimer's Association, Chicago, IL, USA. · Department of Neurosciences, University of California, San Diego, San Diego, CA, USA∥ · Pubmed 26402088
  • AXA Research Fund & UPMC Chair, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) & Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, Paris, France. · Institute for Aging and Alzheimer's Disease Research & Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Centre Mémoire de Ressources et de Recherche (CMRR) Paris Nord Ile-de-France, Groupe Hospitalier Saint Louis Lariboisière - Fernand Widal, Université Paris Diderot, Paris 07, Paris, France. · Institut du Fer à Moulin (IFM), Inserm UMR_S 839, Paris, France. · University College London Institute of Neurology, Queen Square, London, UK. · Pubmed 26401553
  • S. Lista, Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) and Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, Paris, France, · Pubmed 25651440
  • Institute for Aging & Alzheimer's Disease Research and Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA. Electronic address: sid.o' · Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical Sciences, Edith Cowan University, Joondalup, WA, Australia. · Nordic Bioscience Biomarkers and Research, Neurodegenerative Diseases, Herlev, Denmark. · Department of Psychology, University of North Texas, Denton, TX, USA. · Quanterix, Inc., Lexington, MA, USA. · AXA Research Fund & UPMC Chair, Paris, France. · Department of Old Age Psychiatry, King's College London, Institute of Psychiatry, London, UK. · Bristol-Myers Squibb, Wallingford, CT, USA. · AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut dela Mémoire et de la Maladie d'Alzheimer (IM2A) & Institut du Cerveau et dela Moelle épinière (ICM), Département de Neurologie, Hôpital de laPitié- Salpétrière, Paris, France; Département de Neurologie, Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière, Paris, France. · Department of Pathology, University of Washington, Seattle, WA, USA. · Clinical Neurochemistry Laboratory, Department of Neuroscience and Physiology, University of Goteborg, Sahlgrenska University Hospital, Molndal, Sweden. · Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA. · Alzheimer's Association, Chicago, IL, USA. · Department of Neurology, Mayo Clinic Jacksonville, Jacksonville, FL, USA. · Department of Neurodegeneration, Center of Neurology, Section for Dementia Research, Hertie-Institute of Clinical Brain Research, University of Tubingen, Tubingen, Germany. · Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Epidemiology, Joseph P Mailman School of Public Health, Columbia University, New York, NY, USA. · Alzheimer's Disease Cooperative Study, Department of Neurosciences, UCSD School of Medicine, La Jolla, CA, USA. · Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA. · Meso Scale Discovery, Rockville, MD, USA. · Department of Medicine, Radiology and Psychiatry, University of California, San Francisco, CA, USA. · Texas Tech University Health Science Center, Garrison Institute on Aging, Lubbock, TX, USA. · Pfizer Inc., New York, NY, USA. · Pubmed 25282381
  • AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · ICM, CNRS UMR 7225, Inserm U 1127, UPMC-P6 UMR S 1127, GH Pitié-Salpêtrière, 47 Bd de l'Hôpital, Paris, France. · INSERM U1027, Toulouse, France. · Faculté de Médecine Université Toulouse III, Toulouse, France. · Department of Epidemiology and Public Health, Toulouse University Hospital, Toulouse, France. · Department of Internal Medicine and Geriatrics, CHU Toulouse, Toulouse, France. · Gérontopole, Toulouse University Hospital, Toulouse, France. · AXA Research Fund & UPMC Chair, Paris, France. · IHU-A-ICM - Paris Institute of Translational Neurosciences, Hôpital de la Pitié-Salpêtrière, Paris, France. · Pubmed 26402073
  • Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilian-University, Munich, Bayern, Germany. Electronic address: · Department of Radiology, University of California San Francisco, San Francisco, CA, USA; Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden. · Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden; Neuropsychiatric Clinic, Malmö University Hospital, Malmö, Sweden. · Alzheimer's disease and other cognitive disorders unit, Neurology Service, ICN Hospital Clinic i Universitari and Pasqual Maragall Foundation, Barcelona, Spain. · Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Nordrhein-Westfalen, Germany; Department of Psychiatry, University Hospital of Lausanne, Lausanne, Waadt, Switzerland. · Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Nordrhein-Westfalen, Germany. · Department of Neurology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland. · Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany. · Department of Psychiatry and Psychotherapy, University Hospital, Tübingen, Germany. · Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilian-University, Munich, Bayern, Germany. · Center of Old Age Psychiatry, Psychiatric University Hospital, Basel, Switzerland. · Department of Biological Regulation, School of Health Science, Tottori University Faculty of Medicine, Yonago, Japan. · AXA Research Fund & UPMC Chair, Paris, France; Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer & Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer & Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, Paris, France. · Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden. · Pubmed 25804998
  • Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France. Electronic address: · INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France. · Hôpital Neurologique Pierre Wertheimer, Lyon, France. · CHRU, Gui de Chauliac, Montpellier, France. · Hôpital Casselardit, Toulouse, France. · Clinique Pasteur, Toulouse, France. · Hôpital Général, Dijon, France. · CHRU, Clinique de Neurologie, Univ Lille Nord de France UDSL, EA1046, Lille, France. · Hôpital Roger Salengro, Lille, France. · Hôpital de la Timone, Marseille, France. · Centre INSERM U897-Epidemiologie & Biostatistique, Université de Bordeaux, Bordeaux, France. · INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France; CENIR, Neuroimaging Unit, ICM, Hôpital de la Salpêtrière, Paris, France. · Eisai SAS, La Defense 2 Cedex, Paris, France. · INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France; Neuroradiology Department, Hôpital de la Salpêtrière, Paris, France. · Pubmed 25596420
2014
  • Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Pavillon François Lhermitte, Hôpital de la Salpêtrière, Université Pierre et Marie Curie, 47 Boulevard de l'Hôpital, 75013, Paris, France, · Pubmed 24807087
  • Center for Advanced Therapeutic Strategies for Brain Disorders, The Roskamp Institute, Sarasota, FL, USA Department of Neurology, Xiangya Hospital, Central South University, Changsha, China. · Department of Psychiatry and Psychotherapy, Alzheimer Memorial Center, University of Munich, Munich, Germany Université Pierre et Marie Curie, Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer, Hôpital de la Salpêtrière, Paris, France. · Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Sahlgren's University Hospital, Mölndal, Sweden. · Université Pierre et Marie Curie, Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer, Hôpital de la Salpêtrière, Paris, France. · Department of Neurology and Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA. · Department of Neurology, Xiangya Hospital, Central South University, Changsha, China. · Department of Neurology, Xiangya Hospital, Central South University, Changsha, China Center for Hormone Advanced Science and Education, Roskamp Institute, Sarasota, FL, USA. · Center for Advanced Therapeutic Strategies for Brain Disorders, The Roskamp Institute, Sarasota, FL, USA Department of Neurology, Xiangya Hospital, Central South University, Changsha, China Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA. · Pubmed 24685635
2015
INSERM France
2018
  • AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013 Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013 Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013 Paris, France. Electronic address: · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013 Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013 Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013 Paris, France. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Department of Neurology, College of Medicine, Hanyang University, Seoul, Republic of Korea; Cell Therapy Center, Hanyang University Hospital, Seoul, Republic of Korea. · Breast and Menopause Clinic, Ghent University Hospital, Corneel Heymanslaan 10, B-9000 Ghent, Belgium. · Department of Physiology and Pharmacology "Vittorio Erspamer", University of Rome "Sapienza", Rome, Italy. · Neuropharmacology Lab, European Brain Research Institute (E.B.R.I.), Rome, Italy. · Neuropharmacology Lab, European Brain Research Institute (E.B.R.I.), Rome, Italy; Department of Biology, University of Rome "Tor Vergata", Rome, Italy. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013 Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013 Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013 Paris, France. Electronic address: · Pubmed 29902481
  • AXA Research Fund & Sorbonne Université Chair, Paris, France. · Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Boulevard de l'hôpital, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy. · Department of Radiology, "Athinoula A. Martinos" Center for Biomedical Imaging, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Department of Physiology and Pharmacology "Vittorio Erspamer", University of Rome "La Sapienza", Rome, Italy. · Institute for Research and Medical Care, IRCCS "San Raffaele Pisana", Rome, Italy. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Department of Neurosurgery, Maxine Dunitz Neurosurgical Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience (TCIN), Trinity College Dublin, Dublin, Ireland. · Unit of Neurosurgery, Azienda Ospedaliera Universitaria Senese, Siena, Italy. · IRCCS "San Giovanni di Dio-Fatebenefratelli", Brescia, Italy. · Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM) Paris, France; Inria, Aramis project-team, Centre de Recherche de Paris, France; Department of Neuroradiology, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France; Department of Neurology, AP-HP, Hôpital de la Pitié-Salpêtrière, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Paris, France. · Sorbonne Université, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM) Paris, France; Inria, Aramis project-team, Centre de Recherche de Paris, France. · IREM, Institute for Regenerative Medicine, University of Zurich, Zürich, Switzerland. · ZNZ Neuroscience Center Zurich, Zürich, Switzerland. · Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Inserm U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle Épinière, ICM, Ecole Normale Supérieure, ENS, Centre MEG-EEG, Paris, France. · Département de Médecine Nucléaire, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · Laboratoire d'Imagerie Biomédicale, Sorbonne Universités, UPMC Univ Paris 06, Inserm U 1146, CNRS UMR 7371, Paris, France. · Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK. · Division of Informatics, Imaging and Data Sciences, University of Manchester, Wolfson Molecular Imaging Centre, Manchester, UK. · Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Functional Neuromodulation, Ltd., Boston, MA, USA. · Centre de NeuroImagerie de Recherche - CENIR, Institut du Cerveau et de la Moelle Épinière - ICM, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Inserm U 1127, CNRS UMR 7225, ICM, Paris, France. · Institut de la Vision, INSERM, Sorbonne Universités, UPMC Univ Paris 06, UMR_S968, CNRS UMR7210, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, CNRS UMR 8256, Institut de Biologie Paris-Seine (IBPS), Place Jussieu, Paris, France. · Department of Biology, University of Rome "Tor Vergata" & Pharmacology of Synaptic Disease Lab, European Brain Research Institute (E.B.R.I.), Rome, Italy. · Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. · Department of Medicine, Surgery and Neurosciences, Unit of Neurology and Clinical Neurophysiology, Brain Investigation & Neuromodulation Lab. (Si-BIN Lab.), University of Siena, Siena, Italy. · Department of Medicine, Surgery and Neurosciences, Section of Human Physiology University of Siena, Siena, Italy. · Berenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. · Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA. · IU Network Science Institute, Indiana University, Bloomington, IN, USA. · NeuroVision Imaging LLC, Sacramento, CA, USA. · ITTM Solutions, Esch-sur-Alzette, Luxembourg. · Casa di Cura "San Raffaele Cassino", Cassino, Italy. · Pubmed 29562524
  • AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Department of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada. · Biostatistics and Special Pharmacokinetics Unit/Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Health Affairs CEO, UCI Health, University of California, Irvine, CA, USA. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Neurological Surgery, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Anatomy & Neurobiology, University of California Irvine School of Medicine, Irvine, CA, USA. · Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Neurology/Psychiatry/Ophthalmology Unit, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. · Foundational Neuroscience Center (FNC), AbbVie Neuroscience, Cambridge, MA, USA; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK; Institute of Neurodegenerative Diseases, Catholic University of Leuven, Leuven, Belgium. · Department of Neurology, Translational Laboratory and Biorepository, University of California Irvine School of Medicine, Irvine, CA, USA. · College of Sciences, One UTSA Circle, The University of Texas at San Antonio, San Antonio, TX, USA. · Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. · Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. · Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · Pubmed 29458203
  • Genetadi Biotech S.L. Parque Tecnológico de Bizkaia, Derio, Bizkaia, Spain. · AXA Research Fund & UPMC Chair, F-75013, Paris, France. · Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, F-75013, Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Boulevard de l'hôpital, F-75013, Paris, France. · Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. · Pubmed 29512064
  • AXA Research Fund & Sorbonne Université Chair, Paris, France; Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Department of Radiology, "Athinoula A. Martinos" Center for Biomedical Imaging, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · AXA Research Fund & Sorbonne Université Chair, Paris, France; Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK; UK Dementia Research Institute, London, UK. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Psychosomatic Medicine, University of Rostock & DZNE Rostock, Rostock, Germany. · AXA Research Fund & Sorbonne Université Chair, Paris, France; Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France; IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Sorbonne Université, AP-HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié-Salpêtrière, Paris, France; Institut du Cerveau et de la Moelle Épinière (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Paris, France. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Casa di Cura "San Raffaele Cassino", Cassino, Italy. · Pubmed 29328927
  • Neurodegenerative Disorder Research Center and Brain Bank, Material Science at Microscale National Laboratory, School of Life Sciences, Key Laboratory of Brain Function and Disease, Chinese Academy of Sciences, University of Science and Technology of China, Hefei; Center for Advanced, Therapeutic Strategies for Brain Disorders, Sarasota; Department of Neurology, University of Florida College of Medicine, Gainesville, Florida. · Roskamp Institute, Sarasota. · Memory Center, Sarasota. · Department of Economics, Arizona State University, Tempe, Arizona. · Paris Institute of Translational Neurosciences IHU-A-ICM, Pitié-Salpêtrière University Hospital; AXA Research Fund & Université Pierre et Marie Curie Chair, Sorbonne Universités, Université Pierre et Marie Curie Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle. · Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen; Center of Old Age Psychiatry, Psychiatric University Hospital, Basel, Switzerland. · Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen. · Department of Psychiatry and Psychotherapy, Alzheimer Memorial Center, Ludwig-Maximilian University, Munich, Germany. · Department of Neurology and Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, Georgia. · Department of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden. · Beijing Anding Hospital, Capital Medical University & Beijing Key Laboratory of Mental Disorders, Beijing; Beijing Institute for Brain Disorders, Beijing, China; Center for Hormone Advanced Science and Education, Sarasota. Electronic address: · Paris Institute of Translational Neurosciences IHU-A-ICM, Pitié-Salpêtrière University Hospital; AXA Research Fund & Université Pierre et Marie Curie Chair, Sorbonne Universités, Université Pierre et Marie Curie Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle; Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer, Hôpital Pitié-Salpêtrière, Paris, France. · Pubmed 28359566
2017
  • AXA Research Fund & UPMC Chair, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et dela moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), HôpitalPitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX, USA. · The Torsten Söderberg Professorship in Medicine at the Royal Swedish Academy of Sciences, Stockholm, Sweden. · AXA Research Fund & UPMC Chair, Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) & Institut du Cerveau et de la Moelle Épinière (ICM), Paris, France; Département de Neurologie, Hôpital de la Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Pubmed 28508359
  • a AXA Research Fund & UPMC Chair , Paris , France. · b Département de Neurologie , Sorbonne Universités, Université Pierre et Marie Curie (UPMC), Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital , Paris , France. · c Institute for Healthy Aging , University of North Texas Health Science Center , Fort Worth , TX , USA. · d ARAMIS Lab, Inria Paris , Paris , France. · e Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, Institut du cerveau et la moelle (ICM), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital , Paris , France. · f European Society for Translational Medicine , Vienna , Austria. · g Medical Research Council Centre for Neuropsychiatric Genetics and Genomics , Cardiff University , Cardiff , UK. · h Département de Neurologie , Sorbonne Université, Université Pierre et Marie Curie, Paris 06 UMR S 1127, Institut National de Santé et en Recherche Médicale (INSERM) U 1127 and CIC-1422, Centre National de Recherche Scientifique U 7225, Institut du Cerveau et de la Moelle Epinière, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière , Paris , France. · i President, Federal Institute for Drugs and Medical Devices (BfArM) , Bonn , Germany. · Pubmed 28286989
  • a Department of Clinical and Experimental Medicine , University of Pisa , Pisa , Italy. · b AXA Research Fund UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie , Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital , Paris , France. · c IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli , Brescia , Italy. · Pubmed 28281838
  • AXA Research Fund and UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · IRCCS Centro San Giovanni di Dio, Brescia, Italy. · Department of Nuclear Medicine, Charité- Universitätsmedizin Berlin, Berlin, Germany. · Jung diagnostics GmbH, Hamburg, Germany. · Eli Lilly and Company, Indianapolis, IN, USA. · Department of Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28777748
  • AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. Electronic address: · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Department of Radiology, "Athinoula A. Martinos" Center for Biomedical Imaging, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; The Torsten Söderberg Professorship in Medicine at the Royal Swedish Academy of Sciences, Sweden. · Department of Psychosomatic Medicine, University of Rostock & DZNE Rostock, Rostock, Germany. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France; IRCCS "San Giovanni di Dio-Fatebenefratelli", Brescia, Italy. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy. · Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy; Casa di Cura "San Raffaele Cassino", Cassino, Italy. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · Pubmed 28527630
  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy; Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Psychosomatic Medicine, University of Rostock and DZNE, Rostock, Germany. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France; AXA Research Fund & UPMC Chair, Paris, France; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France. · AP-HP, UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. · Faculty of Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy; Casa di Cura "San Raffaele Cassino", Cassino, Frosinone, Italy. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. Electronic address: · Pubmed 28263742
2016
  • German Center for Neurodegenerative Diseases (DZNE) - Rostock/Greifswald, Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. Electronic address: · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; INSERM U1127, Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France; Sorbonne Universites, Universite Pierre et Marie Curie-Paris 6, Paris, France; CATI Multicenter Neuroimaging Platform, France; IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli, Italy. · German Center for Neurodegenerative Diseases (DZNE) - Rostock/Greifswald, Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; INSERM U1127, Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France; Sorbonne Universites, Universite Pierre et Marie Curie-Paris 6, Paris, France; AXA Research Fund & UPMC Chair, Paris, France. · IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli, Italy. · Inserm, U1127, F-75013, Paris, France; CNRS, UMR 7225 ICM, 75013, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France; Inria, Aramis Project-team, Centre de Recherche Paris-Rocquencourt, France. · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; IHU-A-ICM - Paris Institute of Translational Neurosciences, Paris, France. · Inserm, U1127, F-75013, Paris, France; CNRS, UMR 7225 ICM, 75013, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France; Neuroradiology Department, Hôpital de la Salpêtriere, Paris, France. · Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Departement de Neurologie, Hôpital de la Pitie-Salpêtriere, AP-HP, Paris, France; INSERM U1127, Institut du Cerveau et de la Moelle Epiniere (ICM), Paris, France; Sorbonne Universites, Universite Pierre et Marie Curie-Paris 6, Paris, France. · Pubmed 26876309
  • Université Pierre et Marie Curie, 47 Blvd de l'Hôpital, 75013 Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · INSERM U1127, Institut du Cerveau et de la Moelle Épinière (ICM), Paris, France. · Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France . · CATI multicenter neuroimaging platform (cati-neuroimaging.com), Paris, France . · IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli, Brescia, Italy. · Inserm, U1127, F-75013, Paris, France. · CNRS, UMR 7225 ICM, 75013, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France. · Institut du Cerveau et de la Moelle Épinière, ICM, F-75013, Paris, France. · Inria, Aramis project-team, Centre de Recherche Paris-Rocquencourt, France. · AXA Research Fund & UPMC, Paris, France. · Department of Neuropsychology, Hôpital Neurologique Pierre Wertheimer, Lyon, France. · Hôpital Neurologique Pierre Wertheimer, Lyon, France. · CHRU, Gui de Chauliac, Montpellier, France. · Centre Mémoire/Centre de Recherche Clinique-Gérontopôle, Hôpital Casselardit, Toulouse, France. · Hôpital General, Dijon, France. · Lyon 1 University, Hospices Civils de Lyon, Hôpital neurologique, Service de Neurologie D, Lyon, France. · Université de Lille, Inserm U1171, CHU, Centre Mémoire, 59000, Lille, France. · Université de Lille, Inserm U1171, Service de Neuroradiologie, Hôpital Roger Salengro, Lille, France. · Hôpital de la Timone, Marseille, France. · CENIR, Neuroimaging Unit, ICM, Hôpital de la Salpêtriere, Paris, France. · Eisai SAS, La Defense 2 Cedex, France. · Neurologie de la Mémoire et du Langage, Université Paris Descartes, Sorbonne Paris Cité, INSERM UMR S894, Centre Hospitalier Sainte Anne, Paris, France. · Neuroradiology Department, Hôpital de la Salpêtriere, Paris, France. · Pubmed 27780331
  • Department of Neurology, Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence 'Démences Rares', Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; Department of Neurology, University of Cagliari, Cagliari, Italy. · Service de Médecine Nucléaire, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; Université Pierre et Marie Curie-Paris 6, INSERM, UMR-S 678, Paris, France. · Service de Médecine Nucléaire, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · Department of Metabolic Biochemistry, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), ICM-INSERM 1127, FrontLab, Paris, France. · Department of Neurology, Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence 'Démences Rares', Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), ICM-INSERM 1127, FrontLab, Paris, France. · Department of Neurology, Institut de la mémoire et de la maladie d'Alzheimer, Centre de Référence 'Démences Rares', Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; Institut du Cerveau et de la Moelle Epinière (ICM), ICM-INSERM 1127, FrontLab, Paris, France. Electronic address: · Pubmed 26988428
2015
  • Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France. Electronic address: · INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France; INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France. · Hôpital Neurologique Pierre Wertheimer, Lyon, France. · CHRU, Gui de Chauliac, Montpellier, France. · Hôpital Casselardit, Toulouse, France. · Clinique Pasteur, Toulouse, France. · Hôpital Général, Dijon, France. · CHRU, Clinique de Neurologie, Univ Lille Nord de France UDSL, EA1046, Lille, France. · Hôpital Roger Salengro, Lille, France. · Hôpital de la Timone, Marseille, France. · Centre INSERM U897-Epidemiologie & Biostatistique, Université de Bordeaux, Bordeaux, France. · INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France; CENIR, Neuroimaging Unit, ICM, Hôpital de la Salpêtrière, Paris, France. · Eisai SAS, La Defense 2 Cedex, Paris, France. · INSERM, CNRS, UMR-S975, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6, Paris, France; Neuroradiology Department, Hôpital de la Salpêtrière, Paris, France. · Pubmed 25596420
Martin-Luther-Universitat Halle-Wittenberg
2016
  • Department of Psychiatry, Psychotherapy and Psychosomatics, Martin-Luther-University Halle-Wittenberg, Julius-Kühn-Straße 7, 06112, Halle (Saale), Germany, · Pubmed 26235059
2014
  • Université Pierre et Marie Curie, Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Pavillon François Lhermitte, Hôpital de la Salpêtrière, Paris, France. Electronic address: · Department of Psychiatry, Psychotherapy and Psychosomatics, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany. Electronic address: · Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany; German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, Germany. · Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology, and Radiotherapy, University of Rome "Tor Vergata", Rome, Italy; IRCCS San Raffaele Pisana, Rome and San Raffaele Cassino, Cassino, Italy. · Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy; IRCSS Santa Lucia Foundation, Rome, Italy. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; University College London Institute of Neurology, Queen Square, London, UK. · Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. · Laboratoire de Neuropathologie Raymond-Escourolle, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France. · IM2A - Institute of Memory and Alzheimer's Disease, Paris, France; IHU-A-ICM - Paris Institute of Translational Neurosciences Pitié-Salpêtrière University Hospital, Paris, France. · Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany. · Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Épinière, UMR-S975 Paris, France; Inserm, U975, Paris, France; CNRS, UMR 7225, Paris, France; ICM - Institut du Cerveau et de la Moelle Épinière, Paris, France; INRIA, Aramis Team, Centre de Recherche Paris-Rocquencourt, France. · Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Département de Neurologie, Hôpital de la Pitié Salpêtrière, Paris, France; Université Pierre et Marie Curie, Paris, France. · Federal Institute of Drugs and Medical Devices (BfArM), Bonn, Germany. · IHU-A-ICM - Paris Institute of Translational Neurosciences Pitié-Salpêtrière University Hospital, Paris, France; Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Épinière, UMR-S975 Paris, France; Inserm, U975, Paris, France; CNRS, UMR 7225, Paris, France; ICM - Institut du Cerveau et de la Moelle Épinière, Paris, France. · Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Épinière, UMR-S975 Paris, France; Inserm, U975, Paris, France; CNRS, UMR 7225, Paris, France; ICM - Institut du Cerveau et de la Moelle Épinière, Paris, France; AP-HP, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · The Campaign to Prevent Alzheimer's Disease by 2020 (PAD2020), Potomac, MD, USA. · Department of Neurosciences, University of California, San Diego, San Diego, CA, USA. · Pubmed 24275164
Goethe Universitat Frankfurt
2014
  • Department of Psychiatry, Goethe-University, Frankfurt am Main, Germany. Electronic address: · Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology, and Radiotherapy, University of Rome "Tor Vergata," Rome, Italy; IRCCS San Raffaele Pisana, Rome, Italy. · Department of Radiology, University of California at San Francisco, San Francisco, CA, USA. · Department of Psychiatry, University of Rostock, Rostock, Germany DZNE, German Center for Neurodegenerative Diseases, Rostock, Germany. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; University College London Institute of Neurology, Queen Square, London, UK. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Department of Psychiatry, Goethe-University, Frankfurt am Main, Germany. · Pubmed 23850330
2013
  • Department of Psychiatry, Goethe-University, Frankfurt am Main, Germany. · Pubmed 23432717
  • Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe-University of Frankfurt, Frankfurt am Main, Germany. · Pubmed 22743552
2013
  • Department of Psychiatry, Goethe-University of Frankfurt, Frankfurt am Main, Germany. · Pubmed 23299381
2012
  • Department of Psychiatry, University of Frankfurt, Frankfurt am Main, Germany. · Pubmed 22748938
  • Department of Psychiatry, Goethe University, Frankfurt am Main, Germany. · Pubmed 23007701
4 Other Locations Show
Yearly article counts 071358442210
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.